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Introduction: Lateral elbow tendinopathy (LET), more commonly known as tennis elbow, is 
the most common chronic musculoskeletal pain condition affecting the elbow.  It affects from 
1-3% of active working people.  It is an overuse injury mostly affecting the extensor carpi 
radialis brevis tendon.  There are many treatment approaches for this condition, including 
medical treatment (conservative treatment as well as surgery), physiotherapy, bracing, rest, 
or a ‘wait and see’ approach.  No single intervention has been proven to be more efficient 
than another.  Radial shockwave is a non-invasive modality, and may be an alternative 
treatment option.  There is conflicting evidence regarding the effectiveness of radial 
shockwave treatment for lateral elbow tendinopathy.  Although it has been reported to be 
effective in some trials, in others it was no more effective than the placebo.  Good quality 
evidence of effective physiotherapy-based treatment (such as radial shockwave) for chronic 
lateral elbow tendinopathy is lacking. 
 
The primary aim of this study was to determine the effects of radial shockwave therapy in the 
treatment of chronic lateral elbow tendinopathy.  A non-randomised controlled trial was 
conducted for this purpose, consisting of an intervention and a control group, comparing 
radial shockwave treatment to placebo treatment.  Patients were selected that had persistent 
(three months and longer) symptoms of chronic lateral elbow tendinopathy not responding to 
conservative treatment, and complying to the inclusion criteria. 
 
 
Methods: Forty-one participants were included in the study; they were systematically 
assigned to either an intervention or control group.  They received one treatment per week 
for three weeks of either radial shockwave or placebo treatment, as well as an eccentric 
exercise program.  
 
Their pain levels, grip strength and upper limb function were assessed at baseline, one week 
and three months’ post treatment.  The data were collected and statistical analysis done 
using the Mann-Whitney U test as well as the Fisher Exact test. 
 
Results: There was no statistical significance found for pain, grip strength and upper limb 
function in patients with chronic lateral elbow tendinopathy treated with radial shockwave 
therapy, compared to patients receiving placebo treatment. 
 
v 
Conclusion: The intervention group presented similarly to the control group. The null 
hypothesis was thus accepted in this study.  There are notable limitations to this study such 
as the small sample size, as well as the many treatment variables (type of shockwave and 
application methods used), and protocols (dosage-intensity, specifications of apparatus, 
focal energy, treatment frequency, localisation methods and combination of therapies) 
available when using radial shockwave treatment.  Therefore, further research is required 
with larger sample sizes and specific treatment parameters to find an effective treatment 
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1. BACKGROUND AND PURPOSE 
 
1.1 INTRODUCTION 
Tennis elbow or better known as lateral elbow tendinopathy (LET) by clinicians, is a 
musculoskeletal disorder presenting with pain and discomfort over the lateral part of 
the elbow, with the onset of the pain being gradual (Waseem et al., 2012).  Other 
symptoms of lateral elbow tendinopathy include weakness of the forearm muscles, 
decreased grip strength, as well as dysfunction of the upper extremity.  The most 
common functional limitation of patients with lateral elbow tendinopathy includes 
movements of the upper limb with elbow extension and forearm pronation, as well as 
handling of objects (Bisset and Vicenzino, 2015). 
  
1.1.1   Tendinopathy 
Previously, the term tendinitis was used to describe pain associated with tendon 
overuse.  Research indicates tendons exposed to overuse demonstrate little or no 
inflammation, although the aetiology of tendinitis suggests an inflammatory process   
(Weinreb et al., 2014).  Although there are no inflammatory cells present in the 
affected or surrounding area, it does not imply that inflammatory mediators is not  a 
contributing factor to tendinopathies (Rees, Stride and Scott, 2006; Riley, 2008 and 
Kaux et al., 2011).  The literature suggests that localised tendinopathies pertain more 
to degenerative than inflammatory processes (Dirks and Warden, 2011; Chan and Fu, 
2012 and Weinreb et al., 2014). It is possible that degeneration and inflammation are 
not opposing each other, but work together in the pathogenesis of tendinopathy 
(Abate et al., 2009). 
 
The degenerative process of tendinopathy is characterised by fibroblasts, vascular 
hyperplasia, and disorganised collagen in the tendon, as well as ineffective vascular 
supply to the affected area (Cook and Purdam 2009; Abate et al., 2009; Kaux et al., 
2011; Weinreb et al., 2014).  During injury or disease when circulation has been 
impaired in the damaged tissues new blood vessels (neovascularization) and nerves 
(neonerves) are formed.  These neonerves may be a contributor, or even be 
responsible for the pain in chronic tendinopathy (Tol, Spiezia and Maffuli, 2012; Rees, 
Stride and Scott, 2013).  
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There may also be signs of neurogenic inflammation in tendinopathies.  This further 
supports the possibility that tendinopathy could be related to the central nervous 
system which in turn could relate it to the chronic pain cycle (Alfredson and Cook, 
2007).  A lecture on sensory motor system studies presented by Vicenzino during an 
International Scientific Tendinopathy Symposium held in Vancouver (2012), strongly 
associates central nervous system involvement with lateral elbow tendinopathy (Scott 
et al., 2012). 
 
1.1.2    Lateral elbow tendinopathy 
Lateral elbow tendinopathy is usually caused by overuse of wrist and forearm 
movements such as wrist extension, pronation and supination. The same wrist 
movements involved when playing tennis can intensify symptoms, hence the term 
“tennis elbow" (Hall and Brody, 1999).  Lateral elbow tendinopathy is prevalent in 
approximately 1-3 % of the general population (Kohia et al., 2008; Bisset and 
Vicenzino, 2015).  The characteristic patient with lateral elbow tendinopathy is aged 
between 45-54  (McMurtrie and Watts, 2012).  Men and woman are equally affected, 
with the dominant arm being more symptomatic (Calfee et al., 2008).  It is generally a 
work, or sport related disorder of the upper limb (Stasinopoulos and Johnson, 2005). 
 
While often perceived as an irritating condition, lateral elbow tendinopathy can be 
quite painful and may limit patients with this condition to do their work or to 
participate sport and social activities.  This condition is often diagnosed in tennis 
players (as high as 40% - 50%), with many of those affected (as much as 15%) being 
workers doing physically strenuous jobs (for example workers using hand-held tools 
such as painters and manual labourers), where patients are required to participate in 
activities involving overuse of the elbow, forearm and wrist (Baskurt, Ozcan and 
Algun, 2003).  
 
Lateral elbow tendinopathy is usually caused by pathology of the extensor carpi 
radialis muscle (Janikowska and Chomiuk, 2013).  Lateral elbow tendinopathy 
(Coombes, Bisset and Vicenzino, 2015; Matocha et al., 2015) has also been referred 
to as radio humeral bursitis (Staples et al., 2008), lateral epicondylitis (Afsar et al., 
2015) or lateral epicondylalgia (Luk, Tsang and Leung, 2014; Bisset and Vicenzino, 
2015).  The latest literature still refers to all these terms - lateral epicondylalgia, 
lateral epicondylitis, tennis elbow and lateral elbow tendinopathy.  In this study the 
term lateral elbow tendinopathy will be used as it gives the best description of the 
painful area and pathology.   
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Lateral elbow tendinopathy affects the tendons of the extensor carpi radialis brevis 
(ECRB) muscles and extensor digitorum communis (EDC) muscles. The ECRB is 
most often the source of symptoms.  The tendons become irritated and inflamed, 
causing swelling and pain in the early stages of the disorder (Kohia et al., 2008).  
Resistance applied to wrist extensor muscles during contraction elicits symptoms 
(Janikowska and Chomiuk, 2013). These movements could elicit pain (Bisset and 
Vicenzino, 2015) 
 
1.1.2.1 Pathology of Lateral elbow tendinopathy 
The understanding of lateral elbow tendinopathy pathology has not progressed very 
much since the groundbreaking work done by Kraushaar and Nirschl (1999).   
However, Coombes et al., (2009) presented an integrated model where tissue 
pathology interacts with the nervous system to cause widespread mechanical 
hyperalgesia and motor control deficits, similar to central sensitization in patients with 
chronic pain.  This integrated model can assist clinicians to recognise and treat 
patients with lateral elbow tendinopathy more effectively through clinical reasoning, 
as the aforementioned patients may react differently to the usual clinical interventions 
and may need alternative treatment methods to address the dysfunctional central 
nervous system (Scott et al., 2012). 
 
1.1.2.2 Classification of Lateral elbow tendinopathy 
There are various classifications of tendinopathies (refer to section 2.2 of 
Terminology) such as the classification by Blazina et al., (1973). This classification 
differentiates four stages. However, Nirschl et al., (2003) suggested another 
classification system using staging systems by observing the histology of LET during 
surgery, as well as pain phase systems based on the patient’s feedback of the 
intensity and duration of the pain (Nirschl and Ashman, 2003). 
 
Chronic LET is characterised by persistent activity-related pain that is well localised.     
Most conservative treatments do not alleviate patient’s symptoms (Fu et al., 2010). 
Their symptoms last longer than the normal healing period, as the healing responses 
were initiated, but failed healing of the collagenolytic injury occurred (Fu et al., 2010).  
A typical episode of lateral elbow tendinopathy lasts from six to 24 months (Staples 
et al., 2008).   
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A study conducted in Holland concluded that 10% of patients diagnosed with lateral 
elbow tendinopathy lost work productivity resulting from sick leave secondary to this 
pathology (Struijs et al., 2004).  There are significant economic implications, with up 
to 30% of those affected needing an average of approximately 12 weeks off work 
(Bisset et al., 2003; Wilson and Best, 2005). 
 
1.1.2.3 Treatment of Lateral elbow tendinopathy 
Treatment strategies in the acute stage have been directed at relieving inflammation. 
Conservative options include relative rest, avoidance of painful activities, non-
steroidal anti-inflammatory drugs (NSAIDS), bracing, as well as physiotherapy 
treatment (dry needling, laser, ultrasound and manipulation techniques, as well as an 
eccentric exercise programme), platelet-, autologous blood-, corticosteroid injections 
and shockwave therapy (Kohia et al., 2008; Ozturan et al., 2010).  Corticosteroid 
infiltrations have been proven to be effective for immediate pain relief (Rees, Maffuli 
and Cook, 2009). Radial shockwave is a non-invasive modality that consists of 
single-pulsed acoustic waves.   These waves transmit energy at the junction of two 
materials with different densities for example bone and tendon (Calfee et al., 2008).  
Studies showed that shockwave initiates repair of the tissues by tissue regeneration, 
and facilitates tendon healing after trauma, as well as significantly improving blood 
supply to tissue (neovascularization) and reducing adhesion formation (Wang, 2003; 
Orhan et al., 2004).  Shockwave could be a beneficial treatment to use in the 
remodeling phase of tendon healing. Shockwave has been promoted as being 
effective when used for non-unions and delayed healing bone fractures not requiring 
surgery, thus stimulating bone growth (Mittermayr et al., 2013). The known side-
effects of shockwave are temporary reddening, transient pain, minor local swelling or 
petechial bleeding (Mittermayr et al., 2013).  
 
Surgery is considered when these conservative measures fail to provide pain relief, 
and consists of open, percutaneous, or arthroscopic surgery where debridement of 
the pathological area is done (Ozturan et al., 2010).  Although there are many 
treatment approaches for this condition, no single intervention has been proven to be 
more efficient than another. In a large study published by Szabo et al., (2006) on a 
comparative series of surgical debridement techniques 5.8% of surgeries were 
classified as failures (Calfee et al., 2008), whereas a 3% failure was reported in a 
large study done on surgical results of tenolysis of pathological tendons in lateral 
elbow tendinopathy patients (Cusco et al., 2013).   
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Most of patients diagnosed with lateral elbow tendinopathy will have good outcomes 
with conservative treatment.  LET is usually a self-limiting disorder from which 10% of 
patients will need surgical intervention, the other 90% may recover in a year (Sims et 
al., 2014). 
 
1.1.3    Radial shockwave treatment 
Radial shockwave has been studied as an alternative to surgery for managing lateral 
elbow tendinopathy (Sems, Dimeff and Ianotti, 2006).  The evidence in the literature 
reporting on the effectiveness of radial shockwave for chronic lateral elbow 
tendinopathy is conflicting (Wang, 2012).  There are several clinical trials evaluating 
the efficacy of shockwave treatment in patients with chronic lateral elbow 
tendinopathy with varying results.  Several authors reported good or excellent 
outcomes in their studies (Pettrone and McCall, 2005; Radwan et al., 2007; Collins, 
Hildreth and Jafarnia, 2011).  Pettrone and McCall (2005) found that patients who 
crossed over to shockwave treatment after unsuccessful placebo treatment had 
significantly better results at three months following active treatment.  Their results 
concluded that with placebo treatment, the mean pain score had only improved 
slightly (with 8), whereas during the intervention, the mean pain score had improved 
more (with 42) at twelve weeks.  Comparing the mean pain score during the 
intervention, the patients in the crossover group had significantly improved pain 
scores compared to the placebo treatment group (p=0.339 at baseline, p=0.0027 at 
week 1, and p<0.0001at three months).  
 
 It was found by Radwan et al., (2007) in their study that extracorporeal shockwave 
(ESWT) could be a potentially helpful additional treatment that could be an 
alternative to surgery.  Their study compared the outcome of high-energy 
extracorporeal shockwave therapy in patients with chronic LET to debridement of the 
pathological tendon, and found comparable results of outcomes measures such as 
pain relief, improvement of grip strength and improvement of upper limb function.  
There was a lack of statistical significance in this study that was not attributed to a 
small sample size (n=56) or type - II errors.  It was concluded that extracorporeal 
shockwave treatment is an alternative comparable treatment to that of surgery.  In 
the final analysis of the study done by Collins, Hildreth and Jafarnia, (2011) it was 
concluded that a single dosage of high–energy shockwave performed with local 
anaesthetic was an effective treatment for lateral elbow tendinopathy (p=0.018).  
Contrary to the aforementioned, some authors could not find any clinically relevant 
efficacy for the use of shockwave therapy on lateral elbow tendinopathy when 
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compared to placebo (Chung and Wiley, 2005; Buchbinder, Green and Struijs, 2008).  
Staples et al., (2008) found that there was an overall improvement of pain and 
function even though no clinical meaningful differences were found between the 
extracorporeal shockwave and placebo groups.  However, all of the outcome 
measures at the six week and six-month follow-up visits yielded insignificant results 
when comparing the intervention and placebo group. 
 
Shockwave therapy studies have contradictory outcomes, due to the many variables 
used such as the patient selection techniques, the use of local anesthetic, the 
equipment used, and the different methods of outcome measurement (Wang, 2012).  
Local anesthesia may alter the effect of shockwave on the tissue, or simply prevent 
treating the most painful area due to the analgesic effect of the anesthesia (Pettrone 
and McCall, 2005).   
 
1.1.4    Conclusion 
Lateral elbow tendinopathy is a more complex condition than a simple soft-tissue 
injury of the extensor tendons (Alagesan, Saxena and Ramadass, 2012).  An 
effective and consistent management strategy for lateral elbow tendinopathy remains 
challenging, and that could be a plausible reason why lateral elbow tendinopathy 
becomes a chronic condition.  Both failed conservative and surgical management of 
chronic lateral elbow tendinopathy are motivation for further research. Radial 
shockwave therapy could be an alternative conservative treatment if proven effective. 
 
1.2  PROBLEM STATEMENT 
Lateral elbow tendinopathy is a painful musculoskeletal condition most frequently 
affecting the elbow, limiting participation in sport and work activities, with a tendency 
to become chronic.  It affects between 1 - 3 % of active working people (Janikowska 
and Chomiuk, 2013).  
 
There are many treatment methods for the management of lateral elbow 
tendinopathy ranging from physiotherapy, medical treatment such as NSAIDS, 
injection therapy and surgery.  No single intervention has been proven to be effective 
to manage this condition, and subsequently the condition becomes chronic and limits 
the patient’s activity at work, home and on the sports field. 
 
Radial shockwave therapy could be an alternative management option for lateral 
elbow tendinopathy.  Further proof is needed to substantiate the efficacy of radial 
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shockwave therapy for chronic lateral elbow tendinopathy (Radwan, Elshobi et al., 
2007). 
 
1.3  RESEARCH QUESTION 
            What are the effects of radial shockwave therapy in the treatment of chronic lateral  
            elbow tendinopathy? 
 
1.4  AIM AND OBJECTIVES OF THE STUDY 
The aim of this study was to determine if radial shockwave therapy is an effective 
treatment for chronic lateral elbow tendinopathy.  
 
The objectives of this study were: 
▪ To determine the demographic profile of the study participants. 
 
▪ To compare pain levels between the control and intervention group at baseline, 
one-week as well as three months’ post treatment in patients with chronic lateral 
elbow tendinopathy. 
 
▪  To compare grip strength between the control and intervention group at baseline, 
one-week as well as three months’ post treatment in patients with chronic lateral 
elbow tendinopathy. 
 
▪  To compare upper limb function between the control and intervention group at 
baseline, one-week, as well as three months’ post treatment in patients with 
chronic LET. 
 
1.5 SIGNIFICANCE OF THE STUDY 
This study aimed to provide patients with chronic lateral elbow tendinopathy with an 
effective, non-invasive and cost-effective treatment option to improve their function 
during their daily activities, at work and playing sports.  Radial shockwave is a 
noninvasive therapeutic modality that could be an effective treatment for patients with 
chronic LET, with minimal side-effects. 
 
Radial shockwave therapy remains a controversial treatment option for tendinopathy.  
Further evidence is needed to justify the use of radial shockwave therapy for chronic 
lateral elbow tendinopathy. 
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1.6  RESEARCH HYPOTHESIS 
H1: There will be a significant improvement in upper limb function, grip strength and 
pain in patients with chronic lateral elbow tendinopathy treated with radial 
shockwave treatment, compared to patients receiving placebo treatment. 
 
H0: There will not be a significant improvement upper limb function, grip strength and 
pain in patients with chronic lateral elbow tendinopathy treated with radial 
































2. LITERATURE REVIEW 
 
2.1  INTRODUCTION 
The literature relevant to this study will be discussed in this chapter. A 
comprehensive literature search was done between January 2012 and December 
2016. The following search engines were used for the literature search: Pedro; 
PubMed; Ebscohost and Google Scholar.  The keywords used for the literature 
search were: extracorporeal shockwave, shockwave, radial shockwave, chronic 
lateral elbow tendinopathy, tendinopathy, tendinitis and tennis elbow. 
 
In 1873 F. Runge was the first person to describe lateral elbow tendinopathy    as 
pain originating from the lateral epicondyle of the elbow.  He called this 
“Schreibkrampf”, interpreted as “writer’s cramp” (Donaldson et al., 2013). In 1883 H. 
Morris described lateral elbow tendinopathy using the words “rider’s sprain” 
(Donaldson et al., 2013).  In 1883 the term “Tennis Elbow” was first mentioned by H. 
Major as he associated lateral elbow pain with lawn tennis players (Donaldson et al., 
2013).  Lateral elbow tendinopathy presents with localised pain and tenderness 
medial to the lateral epicondyle, the symptoms are aggravated by gripping of the 
hand, as well as resisted extension of the wrist, middle finger or both (Buchbinder, 














Figure 2.1: Tennis elbow                                                   (Waseem et al., 2012) 
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2.2 TERMINOLOGY 
The term “tendinitis” has often been used to describe pain in the tendon (Brett, 
Andres and Murell, 2008; Rees, Stride and Scott, 2013).  This term is similar to a 
dysfunction where a histopathological description of inflammation in the tendon is 
given, where inflammation is a response of the tendon to injury characterised by pain, 
swelling, redness and heat (Rees, Stride and Scott, 2013).  “Tendinosis” has been 
used to give a histopathological description of the degeneration of the tendon, where 
degeneration is the gradual deterioration of the tendon with loss of function caused 
by injury, without correlation with clinical symptoms and without inflammatory signs.  
In the last few years this theory has gradually developed and the term 
“tendinopathy” has been suggested to clinically diagnose tendon pain (Dirks and 
Warden, 2011).  Tendinopathy refers to the clinical presentation of activity-related 
pain, with a progressive loss of elasticity in the tendon, as well as impaired upper 
limb function.  There could be edema, tenderness and crepitation’s on palpation 
around the affected area (Kaux et al., 2011), as well as intratendinous imaging 
changes (Dirks and Warden, 2011). 
 
There are various classifications of tendinopathy, such as the functional and clinical 
classification of tendinopathy suggested by Blazina et al., (1973):  
 
            Pain after sports activity. 
▪ Pain at the beginning of sports activity that usually disappeared with warm up, 
and often reappeared with exhaustion. 
▪ Pain during activity and at rest. 
▪ Tendon rupture (Kaux et al., 2011).  
  
Another classification of tendinopathy as proposed by Cook and Purdam, (2009) was: 
▪ Reactive tendinopathy. 
▪ Tendon disrepair. 
▪ Degenerative tendinopathy. 
 
Reactive tendinopathy is a reactive response that is a short-term adaptation to 
overload of the tendon, that thickens the tendon, reduces stress and increases 
stiffness in the tendon (Cook and Purdam 2009). 
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The following phases of pain were based on the observed histology during surgery 
for LET, from the patient’s feedback, as well as the intensity of pain and the duration 
thereof (Nirschl and Ashman, 2003):  
 
▪ Phase I: mild pain after exercise, lasting less than 24 hours.  
▪ Phase II: pain after exercise, lasting more than 48 hours, settling with warm-up.  
▪ Phase III: pain with exercise, does not change the activity.   
▪ Phase IV: pain with exercise that changes the activity.   
▪ Phase V: pain caused by strenuous daily living activities.  
▪ Phase VI: intermittent pain at rest that does not interrupt sleep; pain caused by 
moderate daily living activities.   
▪ Phase VII: constant pain at rest, and pain that interrupts sleep. 
 
A chronological classification of tendinopathy is the following: it is classified as 
“acute“the first six weeks ; “sub-acute”  from six to twelve weeks, and as “chronic” if 
symptoms persist for more than three months (Kaux et al., 2011). 
 















Figure 2.2: Anatomy of the Elbow                                              (Netter, 2011)   
 
The anatomical structures involved with lateral elbow tendinopathy are the common   
extensor origin.  The ECRB muscle is mostly affected, with or without involvement of  
the EDC (De Smedt et al., 2007).           
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The elbow joint (Figure 2.2) consists of the bony anatomy and ligaments.  The bony 
components are the distal humerus, proximal radius and ulna.  The elbow joint 
comprises three joints, the proximal radioulnar joint, humeroulnar joint and 
humeroradial joint are the articulations that form the elbow complex (Hoogenboom, 
Voight and Prentice, 2014).  The movements of the elbow are pronation, supination 
as well as flexion and extension.  The radial collateral ligament originates from the 
lateral epicondyle and attaches to the annular ligament.  The ulnar collateral ligament 
arises posterior to the radial collateral ligament and passes superficially to the 
annular ligament to attach to the bony tubercle of the ulna.  The function of these 
ligaments is to stabilise the elbow. These ligaments are specialised thickenings of the 
joint capsule (Waseem et al., 2012). 
 
The capsule is continuous among the three articulations and highly innervated, and 
plays an  important role in  joint support and proprioception (Hoogenboom, Voight 
and Prentice, 2014).  The posterior part of the capsule is taut in flexion and becomes 
lax with extension and vice-versa (Waseem et al., 2012). 
 
There are seven bursae surrounding the elbow.  The radio humeral (sub extensor 
carpi radialis brevis) bursa is located deep to the common extensor tendon, below 
the brevis and superficial to the radio humeral joint capsule.  This bursa has been 
identified and mentioned by several authors in the aetiology of lateral elbow 
tendinopathy. It was stated by McVay (1984) that radioulnar bursitis may occur from 
the irritation of repeated wrist extension with the forearm in  pronation (Waseem et al., 
2012). 
 
The common extensor origin consists of the combined tendons of ECRB, EDC and, 
to a lesser extent, extensor carpi ulnaris (ECU) (Donaldson et al., 2013).  The ECRB 
originates from the lateral inferior aspect of the lateral epicondyle and is covered by 
the ECRL and its fibres that are almost indistinguishable from those of the ECRL and 
EDC in most cases.  The ECRB muscle also has additional attachment to the radial 
collateral ligament and the intermuscular septa between it and common extensor 
muscle.  The ECRB tendon inserts to the dorsal surface of the base of the second 
metacarpal bone.   
The extensor carpi radialis longus (ECRL) originates from the supracondylar ridge 
below the origin of the brachioradialis, the origin is between the brachialis medially 
and the ECRB inferolaterally.  The ECRL crosses the elbow and carpal joint to insert 
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onto the dorsal base of the second metacarpal and is covered by the brachioradialis 
over most of the forearm.   
The EDC originates from the anterior distal aspect of the lateral epicondyle and 
accounts for most of the contour of the extensor surface.  Parts of the EDC are also 
attached to the septum and tendon from which the ECRB surfaces.  The action of the 
ECRL is wrist extension, radial deviation, and possibly elbow flexion, whereas the 
main action of the ECRB is wrist extension with some assistance in radial deviation.  
(Waseem et al., 2012). 
 
2.4 EPIDEMIOLOGY 
           
 2.4.1 Prevalence 
Lateral elbow tendinopathy is prevalent in 1.3% of the general population globally 
(De Smedt et al., 2007; Staples et al., 2008; Shiri and Viikari-Juntura, 2011).  
Prevalence varies between 0.3% and 13.5% in working populations globally, and is 
most commonly found in manually intensive occupations (Shiri and Viikari-Juntura, 
2011).  
 
There is an equal distribution between men and women, with the highest occurrence 
in those aged between 45-54 years (Longo et al., 2012; McMurtrie and Watts, 2012).  
Symptoms are more commonly seen in the dominant arm (Calfee et al., 2008; Longo 
et al., 2012).  It seems to occur equally among blue-collar and white-collar workers, 
and amongst all socio-economic classes (Waseem et al., 2012). 
 
2.4.2    Incidence 
There is a reported incidence of lateral elbow tendinopathy of up to 4-7/1000 patients 
per year worldwide (Longo et al., 2012; McMurtrie and Watts, 2012).  The incidence 
rate of medical consultations in medical practices in Europe has been estimated at 
0.3 - 1.1% for lateral elbow tendinopathy per year per 100 patients (Shiri and Viikari-
Juntura, 2011).  The incidence rate in the working population is slightly higher than 
the general population at 2-4% for lateral elbow tendinopathy (McMurtrie and Watts, 
2012; Longo et al., 2012).  In a study that included 94 tennis players in five very 
active tennis clubs, Nirschl (2015) found that the incidence of lateral elbow 
tendinopathy was present in more than 50% of tennis players.   
 
The natural progression of this condition seems to be positive, with spontaneous 
healing within one to two years in 80 to 90 per cent of patients (Waseem et al., 2012).  
14 
Lateral elbow tendinopathy is normally a self-limiting disorder, and lasts between six 
and 24 months (Chesterton, Mallen and Hay, 2011). 
 
2.4.3 Impact 
Lateral elbow tendinopathy has a substantial impact both on athletes and in the 
workplace (Longo et al., 2012). Lateral elbow tendinopathy causes functional 
disability due to productivity loss, and is costly due to high health-care use (Shiri and 
Viikari-Juntura, 2011).  Even in the acute stage a substantial number of workers with 
lateral elbow tendinopathy reported a loss of productivity in their working environment.  
The average length of sick leave for workers with lateral elbow tendinopathy is close 
to two weeks (Shiri and Viikara-Juntura, 2011).  Between 10–30% of patients with 
lateral elbow tendinopathy have an extended period of sick leave of as much as 
eleven to twelve weeks (Shiri and Viikara-Juntura 2011).  In a study by Walker–Bone 
et al., (2012) it was stated that approximately 5% of workers diagnosed with lateral 
elbow tendinopathy consequently took sickness absence.  The estimated time of 
work loss was 29 days in 12 months.  According to Chesterton, Mallen and Hay, 
(2011) up to 30% of workers with LET report being absent from work because of 
lateral elbow tendinopathy.  Lateral elbow tendinopathy can cause a change of a 
worker’s occupation because of the physical strain of some types of occupations.  
Moreover, it may restrict leisure time activities such as certain sport and hobbies 
(Shiri and Viikari-Juntura, 2011). 
 
2.5 AETIOLOGY 
The aetiology of tendinopathy is currently still a challenge, and many probable 
causes have been suggested such as ischemic damage, matrix metalloproteinase 
imbalance, hypoxia, inflammatory mediators, oxidative stress, hyperthermia, 
fluoroquinolones, and impaired apoptosis (Sharma and Maffuli, 2006).   
 
Lateral elbow tendinopathy is most probably caused by overuse of the ECRB muscle, 
alone or in combination with the EDC (De Smedt et al., 2007).  The onset of 
symptoms is usually caused by an overuse of the upper extremity by using repetitive 
wrist extension in combination with alternating forearm pronation/supination 
movements.  Another cause of LET could be a work  history of repetitive  manual 
tasks causing significant strain such as manual labour with heavy tools (Longo  et al., 
2012).  Overuse is what initially causes this condition, which then causes micro 
tearing of tendon fibres.  Thereafter there is a complex process taking place 
predominantly in the areas of poor blood supply such as tendons.  Overload not only 
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affects the matrix components (collagen and proteoglycans), but also elicits an 
essential response in tenocytes that appears designed to adapt the matrix to the 
increased load.  Matrix load is transmitted into the cell and alters protein and enzyme 
production. Tensile load itself can actually cause in situ cell nucleus deformation.  
Mechanical loading of human tendon fibroblasts increases production of both 
prostaglandin E2 and leukotriene B4, and these intermediaries can contribute to the 
tendon changes discovered in tendinopathy (Rees and Maffuli, 2009).  Tendinopathy 
causes changes in that the tendon looks grey or yellow-brown and is friable (a solid 
substance that has a tendency to break into smaller pieces with friction), weak and 
flimsy or swollen (Nirschl and Ashman, 2003; Scott and Ashe, 2006). Calcification, or 
the accumulation of lipid cells sometimes replaces the degenerated and degraded 
type one collagen fibres (Abate et al., 2009).  When collagen fibres begin to denature 
(destroy the characteristic properties), it causes a progressive focal area of 
intratendinous degeneration that could lead to partial tears and ruptures (Sharma and 
Maffulli, 2006; Kaux et al., 2011).  
Peripheral local noxious stimulation makes peptidergic group IV fibres release 
peptides from their terminals.  In view of the fact that these neuropeptides such as 
substance P and calcitonin gene-related peptide are in the tendon, there might still 
be inflammation in the tendon.  The release of these peptides triggers various 
pathophysiological processes contributing to neurogenic inflammation (Alfredson and 
Cook, 2007).   
 
There are many factors that needs to be taken into consideration in the aetiology of 
lateral elbow tendinopathy, such as internal or external factors.  These factors work 
either in isolation or in combination with each other.  When there are intrinsic risk 
factors involved such as malalignment and biomechanical factors, excessive loading 
may contribute to cause the tendinopathy (Sharma and Maffuli, 2006). 
 
Tendinopathy can also be associated with medical conditions such as diabetes, 
obesity, hypertension, high cholesterol, and other metabolic factors.  Metabolic 
disease such as atherosclerosis and impaired glucose metabolism have been 
identified as contributing factors in tendinopathy.  In conditions such as diabetes and 
inflammatory disorders (rheumatoid arthritis), the peripheral nervous system has 
been identified as a common cause of failed healing of connective tissue and 
malfunction of homeostasis (Ackerman and Renstrom, 2012).  Certain drugs such as 
treatment for high cholesterol with statins, and quinolone antibiotics should be 
avoided among active sports participants, as it has been associated with an 
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increased risk of tendinopathy (Ackerman and Renstrom, 2012).  Low molecular 
weight heparin and immunosuppressive drugs such as cortisone (especially 
intratendinous) and cyclosporine may have harmful effects on tendon metabolism 
and repair, and should be used with caution as it could cause rupture of the tendon 
(Ackerman and Renstrom, 2012). 
 
2.6  RISK FACTORS FOR LATERAL ELBOW TENDINOPATHY 
2.6.1  General Risk Factors   
Controversy exists in the literature regarding the risk factors contributing to lateral 
elbow tendinopathy.  Mesenchymal syndrome has a genetic component that could 
cause abnormal collagen formation.  Patients with this syndrome are likely to have 
more than one area of tendinopathy that may include, carpal tunnel syndrome, 
rotator cuff pathology, lateral elbow tendinopathy, trigger finger and De Quervan’s 
disease.  In other studies many of these tendinopathies such as rotator cuff 
pathology, De Quervan’s disease and carpal tunnel syndrome have been associated 
with lateral elbow tendinopathy (Walker-Bone et al., 2004; Abate et al., 2009; 
Titchener, Fakis et al. 2013).  A large case-controlled study including 4 998 patients 
conducted by Titchener et al., (2012) used a database from the Health Improvement 
Network to quantify and assess the intrinsic and extrinsic risk factors for lateral elbow 
tendinopathy in the general population (United Kingdom). The study randomly 
selected patients out of a database of approximately 50 000 with a diagnosis of 
lateral elbow tendinopathy from 2 000, and the placebo’s were individually matched 
to each patient by age, gender and general practice.  Through multivariate analysis 
the following was found to be associated risk factors for lateral elbow tendinopathy: 
oral corticosteroid therapy (OR 1.68), rotator cuff pathology (OR 4.95), De Quervan’s 
disease (OR 2.48), carpal tunnel syndrome (OR 1.50), and a history of previous 
smoking (OR 1.20).  Rotator cuff pathology was very strongly associated with lateral 
elbow tendinopathy whereas diabetes, current tobacco use, alcohol intake, 
rheumatoid arthritis, trigger finger and obesity were not (Titchener et al., 2012).  In a 
smaller cross-sectional study undertaken by Walker-Bone et al., (2012) in 
Southampton (England), they collected data through a physical examination and 
screening a long questionnaire and confirmed that being overweight, smoking and 






2.6.2 Occupational Risk Factors  
There are various contributing factors that can predispose patients to lateral elbow 
tendinopathy.  Lateral elbow tendinopathy is strongly associated with work that 
requires as a combination of forceful and repetetive activities, as well as being 
exposed to these activities for a longer length of time (Shiri et al., 2006).  
 
In a review by Van Rijn et al., (2009), they investigated the association between 
occupations, physical and psychosocial risk factors and the occurrence of lateral 
elbow tendinopathy.  Physical risk factors (frequent handling of loads, forceful work 
and highly repetitive movements) were associated with the occurrence of lateral 
elbow tendinopathy.  However, psychosocial risk factors (postural load, low social 
support and low job control) were also associated with lateral elbow tendinopathy.   
In a cross-sectional study of 9 696 randomly selected adults conducted by Walker - 
Bone et al., (2012) it was found that lateral elbow tendinopathy was significantly 
associated with psychological distress, manual work [odds ratio (OR) 4.0,95%, 
CI 1.9,8.4], as well as being associated with reported bending/straightening the 
elbow for more than one hour per day (OR 2.5,95%, CI 1.2,5.5).  Other exposures 
including keyboard use as well as working with arms above shoulder height and 
exposure to hand transmitted vibration, were not significantly associated with lateral 
elbow tendinopathy (Walker-Bone et al., 2012). 
 
2.7  DIAGNOSIS OF LATERAL ELBOW TENDINOPATHY 
Lateral elbow tendinopathy is diagnosed by the patients subjective history and  
physical examination done by the clinician (Shiri et al., 2011).  The diagnosis for LET  
is confirmed if there is pain and tenderness on palpation of the common extensor 
tendon at the attachment of the the lateral epicondyle, resistance of wrist and/or 
middle finger extension elicits pain, as well as pain in gripping and pinching with the 
hand and fingers, and lifting or handling of objects (Longo et al., 2012).  The specific 
test that confirms the diagnosis of LET includes the Tompson maneuver, in which 
pain is elicited by giving resistance to wrist extension with elbow extension and 
forearm pronation.  Several other provocative tests could assist in the diagnosis of 
LET, including the Chair-, Cozen’s-, Bowden’s- and Mill’s test.  By putting the ECRB 
in either eccentric contraction or passive stretching these tests cause pain over the 
lateral epicondyle (Luk, Tsang and Leung, 2014).  The elbow is painless during 
passive range of motion testing and whilst at rest (Waseem et al., 2012).  If there is 
clinical uncertainty imaging may be helpful, but it is not usually needed to confirm the 
diagnosis.  Although basic X-rays may show the bony alignment as well as 
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calcification of the tendons, ultrasonography and magnetic resonance imaging (MRI) 
are the more specialised imaging modalities, and will show an abnormal signal within 
the tendon origin (McMurtrie and Watts, 2012).  On sonography of elbow 
tendinopathy, the tendon seems poorly defined.  There is decreased echogenicity of 
the tendon, and thickening or thinning of the tendon is visible.  On MRI of lateral 
elbow tendinopathy, there are areas of thickening, and high signal intensity of the 
tendon.  Ultrasonography is more cost-effective; however, it is not as accurate as 
MRI.  When diagnosing lateral elbow tendinopathy MRI is the most effective 
procedure, but also the most expensive (Shiri et al., 2011).   
 
2.8  DIFFERENTIAL DIAGNOSIS OF LATERAL ELBOW TENDINOPATHY 
During the examining of the patient with LET, the source of pain should be at the 
lateral epicondyle.  If the painfull area is a wider generalised lateral elbow pain, the 
clinician should reconsider their diagnosis (McMurtrie and Watts, 2012).  The 
differential diagnosis of lateral elbow tendinopathy includes posterior interosseous 
nerve entrapment syndrome, referred pain from the cervical spine or shoulder, 
osteoarthritis, osteochondral lesions of the radiocapitellar joint, varus or postero-
lateral rotatory instability due to ligament laxity, a loose body or synovial plica 
(McMurtrie and Watts, 2012). 
 
2.9  MANAGEMENT OF LATERAL ELBOW TENDINOPATHY 
The available evidence for managing tendinopathies is limited.  Although there are 
many  treatment options available, very few randomised placebo-controlled trials 
have been done to guide medical practitioners in making an informed decision on the 
best evidence-based treatment options (Maffuli et al., 2010). 
 
In a literature review undertaken  by Ozturan et al., (2010) it was mentioned that 
treatment strategies in the acute stage have been directed at relieving inflammation.  
Conservative options include non-steroidal anti-inflammatory drugs, corticosteroid 
injections, rest, activity modification, bracing as well as physiotherapy treatment (dry 
needling, laser, ultrasound and manipulation techniques, as well as an eccentric 
exercise programme), autologous blood injections, platelet-rich plasma injections, 
and shockwave therapy.  Surgery is considered when the conservative management 




In a clinical trial undertaken by Ozturan et al., (2010) that included 60 patients 
diagnosed with LET, they compared the short-, medium- and long-term effects of 
corticosteroid injections, autologous blood injection and extracorporeal shockwave 
using pain, grip strength and upper limb function as outcome measures.  Their 
results concluded that treatment with corticosteroid injections provided symptomatic 
pain relief in the short term, but there was a high recurrence rate for LET.   However, 
autologous blood injections and extracorporeal shockwave therapy yielded better 
long-term results.  A limitation of this clinical trial is that there was no control group, 
as well as the small sample size. 
 
2.9.1  Medical Management 
The medical management of lateral elbow tendinopathy that will be discussed is the 
conservative options, injection therapy as well as surgery. 
 
2.9.1.1 Conservative management 
The conservative options that will be discussed are non-steroidal anti-inflammatory 
drugs, nitroglycerine and bracing. 
 
2.9.1.1.1 Non-steroidal anti-inflammatory drugs 
What may present as an “acute tendinopathy” clinically is in fact a failed 
healing process in chronic lateral elbow tendinopathy, where there are no 
signs of inflammation.  The results for the efficacy of the many available 
pharmaceutical treatment options yielded controversial results when tested in 
randomised controlled trials (Maffuli et al., 2012).  The literature known to us 
suggests that when there is no active inflammatory process present, there is 
no clinical reason to support the use of non-steroidal anti-inflammatory drugs 
for the treatment of chronic LET (Maffuli et al., 2010).   
 
In a Cochrane collaboration review published by Pattanittum et al., (2013) 15 
randomised or quasi-randomised controlled trials were reviewed involving 664 
participants comparing topical NSAIDS or oral NSAIDS to placebo.  The 
results were inconclusive and conclusions about the benefits or 
disadvantages of topical or oral NSAIDS when treating lateral elbow 
tendinopathy could not be made.  Although data from five placebo controlled 
trials suggest that topical non-steroidal anti-inflammatory drugs may be 
beneficial for pain relief (lasting up to four weeks), non-normal distribution of 
data (indicating limited trials with risk of bias), and other methodological 
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issues (no blinding and concealed allocation, appropriateness of sequence 
generation used, management of incomplete outcome data) precluded firm 
conclusions.  Evidence about the advantages of oral non-steroidal anti-
inflammatory drugs have been inconclusive, however oral non-steroidal anti-
inflammatory drugs may result in gastrointestinal side-effects in some patients.  
This is confirmed by a review done by Erickson and Hall, (2015) where there 
was a higher incidence of gastrointestinal related side-effects in patients with 
LET treated with oral NSAIDS. 
 
2.9.1.1.2 Nitroglycerine  
Topical nitroglycerine (glycerol trinitrate) or (GTN) is a treatment option that 
can be used by applying the GTN patch over the site of lateral elbow 
tendinopathy.  GTN patches contain organic nitrate that produces nitric oxide, 
which stimulates tendon healing, probably by stimulating fibroblastic 
production of collagen (Valen and Foxworth, 2010).   
There is some controversy in the literature about the efficacy of GTN.  In a 
randomised, double-blinded, placebo-controlled trial conducted by Paoloni et 
al., (2003) consisting of 86 participants with LET, continuous topical GTN 
combined with exercise rehabilitation done daily, was effective in reducing 
pain levels with activity at two weeks, tenderness at six and twelve weeks, 
and there were asymptomatic patient outcomes at twenty-four weeks.  In 
another study by the aforementioned authors three different doses of 
continuous topical GTN in combination with a daily stretching programme 
yielded a significant reduction in pain with elbow activity after treatment, but at 
eight weeks the outcome was insignificant (Paoloni et al., 2008).   
 
In a comparative study including 58 patients done by McCallum, Paoloni and 
Murrell, (2011) it was found that while GTN appeared to offer short-term 
benefits (up to six months) in the treatment of lateral elbow tendinopathy, 
there was no significant clinical long-term benefits (at five years) when 
compared with patients that only received a standard tendon rehabilitation 
programme.   
 
The standard tendon rehabilitation programme included the best practice 
management for lateral elbow tendinopathy at the time. The programme 
consisted of resting from pain provoking activities in the acute stage 
(especially repetitive wrist and forearm movements, as well as forceful 
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gripping), wearing a counter force brace until the completion of the first phase 
of the muscle-strengthening programme, regular stretching of the ECRB 
muscle, as well as a progressive muscle-strengthening programme whilst 
gradually increasing the resistance (Paoloni et al., 2003).  
 
2.9.1.1.3 Bracing 
The two braces used most often in the treatment of LET is the wrist extension 
brace and the proximal forearm strap (counter force brace).  The wrist 
extension brace keeps the wrist in this position, and is considered to unload 
the extensor origin and relax the wrist extensors. One explanation as to how 
the counter force brace could be beneficial for LET is that it reduces the force 
exerted on the common extensor origin, being that its compressive force 
limits expansion and thereby the amount of force generated by the extensors.  
Another is that the brace serves as a secondary origin for the ECRB muscle, 
reducing the force generated proximally.  Both these mechanisms could 
theoretically decrease the mechanical stress on the damaged tendons, 
promoting healing (Sims et al., 2014). 
 
There is some controversy in the literature about the efficacy of bracing for 
lateral elbow tendinopathy.  Work published by Struijs et al., (2004) reported 
short-term improvement in activities of daily living whilst wearing the brace, 
however bracing was found to be no more effective than placebo or physical 
therapy in the treatment of lateral elbow tendinopathy in the long-term (26 
weeks).  Similar findings were published by Bisset et al., (2003), where they 
stated that no firm conclusions on the efficacy of orthotics could be made.  
However, significant improvements were reported by Faes et al., (2006) using 
pain scores and grip strength, comparing a dynamic extensor brace to 
placebo after twelve weeks of use.  The improvement continued at twenty-
four weeks without further use of the brace beyond twelve weeks (Faes et al., 
2006).  While bracing may offer some symptomatic relief in the short-term, its 
long-term effects on symptoms and muscle strength for LET are not well 
documented, and long-term use of the brace could lead to weakening of the 
muscles if the they are not maintained with strengthening exercises.  
 2.9.1.2 Injections 
Injection therapy can be used as an effective second-line therapy in patients that 
present with recalcitrant symptoms of lateral elbow tendinopathy, not responding to 
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conservative therapy, thus preventing surgery in a majority of patients who would 
previously have had no other option than surgery (Creaney et al., 2011). 
 
2.9.1.2.1 Corticosteroid injections 
Corticosteroid injections have been used for pain relief in LET.  The point of 
maximal tenderness, usually over the origin of the ECRB, is injected with 
betamethasone, dexamethasone, and triamcinolone mixed with a local 
anesthetic such as bupivacaine or lidocaine (Sims et al., 2014).  
Corticosteroid injections have been used to give relief of the acute pain of 
lateral elbow tendinopathy, allowing patients to begin early rehabilitation.  
Several clinical trials have compared the efficacy of steroid injections versus 
NSAIDS and placebo treatment.  Although participants experienced a brief 
period of post-injection discomfort, the pain relief during early follow up (five 
days to six weeks) has been shown to be more significant in the steroid group 
when compared to the NSAIDS and placebo group (p≤0.05).  In a study 
conducted by Rees, Maffuli and Cook, (2009) it was confirmed that 
corticosteroid injections have therapeutic value in the short term.  However, at 
long term follow up (three to twelve months), the outcome of those who 
received steroid injections were the same  or even worse than those of the 
other treatment groups who received NSAIDS or placebo (Calfee et al., 2008).  
Worse clinical outcomes were reported by Coombes et al., (2013) one-year 
post corticosteroid injection when compared to placebo injection, and higher 
recurrence rates of LET were demonstrated by Bisset et al., (2006) in the 
corticosteroid injection group.  Corticosteroid injections can give pain relief in 
the acute stage but is not beneficial in the long term and can cause 
reoccurrence (Bisset et al., 2006). 
 
2.9.1.2.2  Autologous blood injections 
Autologous blood injections (ABI) are collected by withdrawing blood from the 
patient and reinjecting the untreated blood into the painful area (Sims et al., 
2014).  Autologous blood injections have also been used for the treatment of 
LET to provide humoral and cellular mediators, and to promote healing in 
areas where failed healing has taken place.  Autologous blood injections 
promote the regeneration of collagen, as well as stimulating the production of 
new blood vessels that may lead to tendon healing (Kaux et al., 2011).  It was 
found in a study undertaken by Creany et al., (2011) which consisted of a 
group of 150 patients that received either PRP (80 participants) or ABI (70 
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participants) injections, that both interventions significantly reduced the pain 
and improved upper limb function of the participants, using the patient - 
related tennis elbow evaluation questionnaire.  The ABI group had a success 
rate of 72%.  
 
Autologous blood injection could be beneficial because it is the simplest 
method of delivering blood derived growth factors containing the growth 
factors in platelets.  However red and white blood cells are also injected 
which have no healing properties.  Consequently, the results of ABI have 
been inconsistent (Dhillon et al., 2014).  
 
2.9.1.2.3 Platelet-rich plasma injections 
Platelet-rich plasma (PRP) contains a high concentration of various growth 
factors such as platelet-derived growth factor, endothelial-growth factor and 
transforming-growth factor beta.  The platelets is collected by withdrawing the 
patients’ blood and centrifuging it to isolate the platelets before re-injecting it 
into the painful area (Sims et al., 2014). 
 
In a systematic review consisting of six studies that was done on the efficacy 
of PRP injections for chronic LET, it was concluded that there was evidence 
indicating that PRP injections was not an effective treatment for chronic LET 
(de Vos, Windt and Weir, 2014).  However, in a double-blind, prospective, 
multicenter (12 centers) controlled trial conducted using two hundred and 
thirty patients with chronic LET treated over a period of five years, it was 
concluded the PRP treatment is a safe treatment option, and results in 
clinically meaningful improvements (in pain scores and elbow tenderness with 
a statistically significant success rate p=0.12) compared with a control group 
(Mishra, Skrepnik et al. 2013).  In a randomised controlled trial conducted by 
Creaney et al., (2011) consisting of eighty patients that received platelet-rich 
plasma (PRP) it was found six months after the intervention that there was a 
success rate of 66% in the PRP group. 
 
Platelet rich plasma appears to be the preferred choice of treatment when 
compared to ABI.  Platelet rich plasma has minimal side-effects.  It is easy to 
apply, is cost effective and it is possible to complete the procedure as a day 
care procedure (Dhillon et al., 2014). 
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2.9.1.2.4 Hyaluronic acid injections  
Hyaluronic acid is an injection treatment that is quite often used in the 
treatment of osteoarthritis.  It was found in certain randomised controlled trials 
that periarticular injections of sodium hyaluronate (a hyaluronic acid derivative) 
was more effective compared to placebo injections (in terms of pain relief) for 
lateral elbow tendinopathy patients (Coombes, Bisset and Vicenzino, 2010; 
Petrella et al., 2010).   
 
It is possible that lateral elbow tendinopathy could have more joint pathology 
involvement than was previously thought.  It could be that cartilage and the 
degenerative tendon have many similarities.  Results of animal studies have 
shown that hyaluronic acid could improve tendon healing (Orchard and 
Kountouris, 2011).  A randomised clinical trial conducted by Petrella et al., 
(2010) included 331 racquet sport athletes.  The objective of this clinical trial 
was to determine if peri-articular hyaluronic acid injections was safe and 
effective treatment option for the treatment of chronic LET.  Peri-articular 
hyaluronate acid injections for LET gave significantly better results compared 
to the placebo group, by improving pain at rest, and after maximal grip testing. 
 
2.9.1.2.5 Prolotherapy 
Prolotherapy is a regenerative injection treatment that has been used for pain 
relief in chronic lateral elbow tendinopathy.  The tender tendon attachments 
are usually injected with a small amount of a sclerosing mixture such as 
sodium morrhuate (an extract of cod liver oil) and dextrose.  It is rationalised 
that prolotherapy may strengthen and enlarge tendon insertions (Chesterton, 
Mallen and Hay, 2011).  A pilot study conducted by Scarpone et al., (2008)   
concluded that prolotherapy was effective (significance of p≤0.05) in 
improving pain and grip strength when comparing the effectiveness of 
prolotherapy to placebo injection in the treatment of chronic LET.   In another 
pilot study conducted by Rabago et al., (2013) they found significant 
improvements in the intervention group treated with prolotherapy, (with 
regards to the following outcomes: quality-of-life, pain and function measures, 
as well as grip strength) compared to the placebo group treated with a wait–
and-see approach.  Outcomes were compared at baseline, sixteen and thirty-
two weeks.  Although prolotherapy could be effective for patients with 
refractory LET, larger well designed randomised controlled trials need to be 
undertaken (Rabago et al., 2013). 
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2.9.1.2.6 Botulin toxin 
Since the 1990s, botulin toxin, also known as ‘BOTOX’, has become well 
known to the public as an anti-wrinkle drug for cosmetic facial enhancement.  
In 1997, botulin toxin was also injected into the common wrist extensor 
tendon to treat lateral elbow tendinopathy.  Botulin toxin reduces muscular 
activity depending on the dosage used.  The muscle relaxation will last 
between 12 and 16 weeks.  It has been suggested that botulin toxin reduces 
the tension on the tendons by causing incomplete paralysis of the wrist and/or 
finger extensors, and thereby reproducing the effects of surgical release of 
the tendon.  Botulin toxin is also thought to have some analgesic effect (Smidt, 
Dingjan et al. 2011).  Conflicting evidence regarding the effectiveness of 
Botulin toxin for lateral elbow tendinopathy was found in a systematic review 
conducted by Sims et al., (2014).  Hayton et al., (2005) could not find any 
significant differences between the intervention and placebo group with 
regards to pain, grip strength or quality of life in their study.  However, Wong 
et al., (2005) and Espandar et al., (2010) found significant differences in pain 
score but the grip strength score was insignificant.  These injections may 
have adverse effects such as digit paresis and weakness of finger extension 
(Wong et al., 2005). 
 
In summary, injection of PRP or hyaluronic acid would appear to be the most 
reasonable choices of injections considering the good results seen in 
randomised controlled trials according to Donaldson et al., (2013) and Luk, 
Tsang and Leung, (2014). 
 
2.9.1.3 Surgical management 
Estimates suggest that up to 5% of patients who do not respond to conservative 
physical interventions undergo surgery, with variable outcomes reported in the 
literature (Maffuli et al., 2010; Coombes, Bisset and Vicenzino, 2015).  Surgical 
management of lateral elbow tendinopathy is recommended when functional 
disability and pain persist after six to twelve months of nonsurgical management 
(Calfee et al., 2008).  Arthroscopic and percutaneous surgical approaches have also 
been described, (Erickson and Hall, 2015). 
 
In a literature review summarising the evidence regarding treatment of common 
extensor tendinopathy done by Erickson and Hall, (2015) (consisting of 91 references) 
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the following was cited: the surgical technique, now commonly referred to as the 
‘‘Nirschl procedure’’, involved an open excision of the diseased portion of the ECRB 
and subsequent repair of the ECRL and EDC as needed.  Initial short-term results 
were reported as excellent in 75% of patients. Subsequent long-term follow-up 
(minimum ten years) reported by Dunn et al., (2008) demonstrated good to excellent 
results in 84% with an overall improvement rate of 97%.  Coleman, (2010) reported 
95% good to excellent results at a mean of nearly ten year follow - up using a 
modified open technique. 
 
When using the arthroscopic approach, the lateral capsule and enfolded tissue is 
debrided, or the extensor tendon is debrided (Calfee et al., 2008).  It was reported by 
Baker, (2008) that there was 87% patient satisfaction after arthroscopic resection of 
pathologic tissue with a mean follow-up of 10 years.  Cohen and Romeo, (2009) 
compared arthroscopic with open release at two year follow up, and concluded that 
there was no significant difference between the two techniques regarding outcomes.   
However, the arthroscopic group was able to return to work/sport sooner.  In a case-
controlled series published by Solheim, Hegna et al., (2013) 305 elbows were 
followed up for three to six years after either open or arthroscopic surgery for 
common extensor tendinopathy. They reported excellent outcomes with both 
surgeries, but a statistically significant difference in the disability of the arm, shoulder 
and hand (DASH) score improvements was found in the arthroscopic group. 
Furthermore, arthroscopic treatment has the advantage of evaluation for concomitant 
intra-articular pathology at time of surgery.  Complications, including nerve injury, 
have also been reported by Carofino, Bishop et al., (2012) following surgery.  A few 
years ago Koh et al., (2013) reported the use of a percutaneous device (Tenex 
Health, Lake Forrest, California) that allows for precise debridement of pathologic 
tendon tissue via a percutaneous approach under live sonographic guidance. In their 
initial trial of 20 patients, one-year follow-up showed significant improvement in visual 
analogue scale (VAS) and DASH scores with 95 % patient satisfaction.  
 
Sonographic improvements in tendon thickness, reductions in tendon neovascularity, 
and improvement in tendon echotexture were also reported in 85 – 95% of patients 
by six months (Erickson and Hall, 2015). The surgical result for lateral elbow 
tendinopathy is generally encouraging as supported by the work done by Nirschl and 





2.9.2 Physiotherapy Management 
 
2.9.2.1 Treatment modalities 
Physiotherapy is commonly employed as a first-line treatment for lateral elbow 
tendinopathy (Erickson and Hall, 2015).  There are different physiotherapy treatment 
modalities for lateral elbow tendinopathy such as: manual therapy (mobilisation with 
movement), Cyriax (deep transverse frictions combined with Mill’s manipulation), 
stretching and strengthening exercises, electrotherapy (ultrasound, low-level laser 
therapy, and transcutaneous electrical nerve stimulation), taping and dry needling 
(Valen and Foxworth, 2010). 
 
2.9.2.1.1 Manual therapy 
Moderate evidence was found for the short-term effects of various manual 
therapy techniques on pain and grip strength, when used alone or in 
combination with graded exercise.  Mulligan (mobilization with movement) 
techniques that can be used for elbow symptoms (pain and stiffness) is the 
radial head postero-anterior glide and the ulnar-humeral lateral glide.  The 
patient does the pain-producing movement while the physiotherapist applies 
the abovementioned sustained mobilization techniques.  These treatment 
techniques are effective when they provide significant immediate relief (e.g., 
50% reduction in pain and improvement of pain free grip strength); (Coombes, 
Bisset and Vicenzino, 2015).  If these techniques do not improve symptoms 
significantly during treatment, other treatment techniques or modalities should 
be considered using clinical reasoning. 
 
2.9.2.1.2 Electrotherapy 
Low level laser therapy (LLLT), also known as photobiomodulation has been 
shown to accelerate tissue healing, including an increase in collagen 
formation of the affected common extensor tendons (Roberts, Kruse and Stoll, 
2013). 
 
The efficacy of laser treatment for LET has been contested.  In a systematic 
review with adequate design and treatment procedures conducted by Bjordal 
et al., (2008) including 13 RCT (randomised controlled trial) consisting of 730 
participants, low level laser therapy (LLLT) with an irradiation of a 904nm 
wavelength applied to the common extensor tendon insertion at the elbow 
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could be a safe and effective alternative treatment option to corticosteroid 
injections and NSAIDS.  Low level laser therapy also seems to be effective 
when used in conjunction with exercise and stretching programmes.   
 
Ultrasound is a modality that is often used to treat lateral elbow tendinopathy 
patients, it is especially used in the acute phase, as it is readily available in 
most physiotherapy practices, and a safe treatment option (Luk, Tsang and 
Leung, 2014).  Lundeberg et al., (1988) reported that when comparing 
ultrasound to placebo, there was an improvement in pain of lateral elbow 
tendinopathy three months after the ultrasound treatment, but they could find 
no significant difference in global improvement.  Another study compared 
ultrasound to acupuncture and found that both yielded improvements in all 
outcome measures, but there was no significant difference when comparing 
the treatment groups (Davidson, Vandervoort and Lessard, 2001).  It is 
difficult to draw any firm conclusion on the efficacy of ultrasound for lateral 
elbow tendinopathy due to the shortage of high-quality randomised controlled 
trials (Luk, Tsang et al. 2014). 
 
It has been recommended that transcutaneous electrical nerve stimulation 
(TENS) can provide safe and effective pain relief in a wide variety of 
musculoskeletal conditions, and can be applied by patients themselves at 
home.  In a randomised controlled trial undertaken by Chesterton et al., 
(2013), which included 241 participants, it was concluded that TENS as an 
additional treatment option to primary care management of lateral elbow 




Patients with lateral elbow tendinopathy should be educated by reassuring 
them that in all probability, the condition will gradually improve over time with 
rest.  Advice would be to avoid activities that exacerbate symptoms such as 
pain (for example not lifting objects with forearm pronation), to rest, and avoid 
loading of the upper limb.  This advice is very important when rehabilitating 
lateral elbow tendinopathy.  Ergonomic advice may focus on minimising use 
of the wrist in ulnar or radial deviation with work tasks, forceful exertion of the 
upper limb, as well as highly repetitive movements.  Patients should also be 
encouraged to gradually introduce more strenuous tasks, and to lessen pain 
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provoking activities when recurrence of LET is experienced (Coombes, Bisset 
and Vicenzino,  2015). 
 
2.9.2.1.4 Eccentric exercises 
The understanding of eccentric exercise is founded on the musculotendinous 
units that structurally adapt to protect themselves from increased loading and 
thereby preventing injuries. The basic principles in the progression of 
eccentric strengthening programmes are to increase the length of tendon, as 
well as the load and speed exerted on the tendon.  The length of the tendon 
is increased before movement by pre-stretching the tendon, hence there will 
be less strain on the tendon during movement.  During progressive increased 
loading of the tendon, there should be an improvement in the inherent 
strength of the tendon.  Greater force will be generated by increasing the  
contraction speed, (Maffuli  et al., 2010). 
 
Eccentric strengthening exercise has become the preferred choice of 
treatment for tendinopathies since Stanish et al., (1986) first reported its 
effectiveness whilst treating achilles tendinopathy.  However, in a review 
conducted by Raman et al., (2012) it was concluded that patients with LET 
doing any type of exercise (isotonic, eccentric, concentric, isometric, or 
isokinetic strengthening exercises) can all have improvement in outcomes 
measures such as: pain, grip strength, and upper limb function with long term 
follow up.  A review done on eccentric exercise for tendinopathies supported 
its use for LET.  When combining eccentric exercise with passive physical 
therapy patients with chronic LET experienced less pain and disability, thus 
having improved upper limb function, as found in the reviewed study 
“Eccentric training for the treatment of tendinopathies,” by Murtaugh and Ihm, 
(2013).   
 
Cullinane et al., (2014) reviewing 12 studies, with ten being of medium or high 
quality, evaluated the effect of eccentric exercise on the treatment of LET.  
They established that adding eccentric exercise gives positive outcomes.  
Most of the studies in Cullinane’s, (2014) review included eccentric exercise 
combined with other treatment modalities (i.e. ultrasound, stretching, 
iontophoresis).  Based on the reviewed studies, patients that had eccentric 
exercise included in their treatment had better outcomes for pain scores and 
function.  There was only one low quality study in the review by Cullinane et 
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al., (2014) comparing eccentric exercise with placebo, and there was no 
significant difference in their outcome after four weeks.  Although evidence 
shows that eccentric exercise combined  with other treatment modalities gives 
better outcomes, further studies are needed to determine if eccentric exercise 
when used in isolation can significantly improve outcomes (Erickson and Hall, 
2015). 
 
Valen and Foxworth, (2010) reviewed clinical trials and systematic reviews for 
evidence supporting the use of physical modalities, and other conservative 
treatments in selected upper extremity musculoskeletal conditions such as 
lateral elbow tendinopathy, and found that most trials had significant design 
flaws and that conclusive evidence in support of any particular intervention is 
lacking. It should also be noted that some studies have failed to show a 
significant difference between physical therapy and a ‘wait–and-see’ 
approach in the long-term, which most likely represents the natural history of 
disease (Erickson and Hall, 2015). 
 
Although multiple options have been proposed for the treatment of lateral 
elbow tendinopathy, there is no agreement in the literature on when and 
which treatment modalities should be employed.  There is strong evidence 
that combining an eccentric exercise programme with advice, as well as a 
passive physiotherapy modality such as mobilisation techniques, dry needling, 
myofascial release or shockwave therapy will have the best outcome for the 
patient with chronic lateral elbow tendinopathy (Bisset et al., 2006; Jones 
2009; Bisset and Vicenzino, 2015).  However, evidence-based treatment of 
lateral elbow tendinopathy should be implemented when choosing a 
treatment option (Erickson and Hall, 2015).  
 
2.10  SHOCKWAVE THERAPY 
2.10.1 Definition 
Extracorporeal shockwave is a noninvasive procedure in which single pulsed 
acoustic, or sonic, waves are generated outside the body, and focused at a specific 
site within the body as a therapeutic modality (Ioppolo et al., 2014).   
 
2.10.2 History  
The influence of shock waves on biological (human) tissue was first documented on 
castaways who were exposed to water bomb explosions during World War II.  They 
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suffered severe lung injuries, but showed no overt clinical signs of traumatic injury 
(Wang, 2003). Approximately 40 years later, in 1980, high energy focused 
extracorporeal shock waves were first introduced in Munich, Germany, to disintegrate 
urinary stones (i.e. lithotripsy) (Wang, 2003).  Over the ensuing 15 years, more than 
two million patients with nephro-ureterolithiasis were successfully treated with 
shockwaves, with few treatment-related side effects (Mittermayr et al., 2012).  
Extracorporeal shockwave therapy began with an incidental observation of 
osteoblastic response pattern during animal studies in the mid–1980’s that generated 
an interest in the application of extracorporeal shockwave to musculoskeletal 
disorders (Wang, 2012).  At the beginning of the 1990’s, the first reports on high-
energy focused shock wave therapy for calcific tendinopathy of the shoulder was 
published (Mittermayr et al., 2012).  In October 2000, the Food and Drug 
Administration approved extracorporeal shockwave (the Ossatron device) for chronic 
plantar fasciitis, and in 2003 for chronic lateral elbow tendinopathy. Further 
investigations and clinical trials using extracorporeal shockwave had shown clinical 
efficacy of therapeutic shock waves for a variety of orthopaedic pathologies including 
calcific tendonitis of the rotator cuff, lateral elbow tendinopathy, plantar fasciitis, 
achillodynia, and calcaneal spurs (Mittermayr et al., 2012).  During the previous 10 to 
15 years’ (1997-2002) shockwave therapy had emerged as the leading choice in the 
treatment of many orthopaedic disorders (Wang, 2012). 
 
2.10.3 Background 
There is increased emphasis on finding alternative modalities to treat tendinopathies, 
such as extracorporeal shockwave therapy (Valen and Foxworth, 2010).  
Tendinopathy in the chronic stage is mainly a degenerative condition and 
inflammation plays a minor role.  This has led to a shift from treatments that target 
inflammation towards treatment options that promote regeneration.  One of these 
treatments is extracorporeal shockwave therapy, a physical therapy modality that 
uses pressure waves to treat tendinopathy (Van der Worp et al., 2013).  
 
Other clinical applications of ESWT in the treatment of vascular skin lesions include 
chronic post-traumatic, venous and diabetic ulcers (Romeo, Lavanga and Sansone, 
2013).  Extracorporeal shockwave has been shown to be effective in the early stages 
of femoral head osteonecrosis by reducing the extension of the necrotic area, 
avoiding further bone collapse (Romeo, Lavanga and Sansone, 2013).  Bone 
resorption is typical in periodontal inflammation.  In vivo experience has 
demonstrated that shockwaves could enhance alveolar bone regeneration in infected 
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gingivalis tissue (Romeo, Lavanga and Sansone, 2013).  Extracorporeal shockwave 
is also currently one of the newer alternative treatments for cardiac ischemia (Romeo, 
Lavanga and Sansone, 2013). 
 
Radial shockwave has been studied as an alternative to surgery for managing lateral 
elbow tendinopathy for many years (Sems, Dimeff and Iannotti, 2006).  Several 
studies investigated the effect of shockwave therapy in patients with lateral elbow 
tendinopathy with varying results.  Several authors reported good or excellent 
outcomes in their studies (Wang and Chen, 2002; Pettrone and McCall, 2005; 
Radwan et al., 2007; Collins, Hildreth and Jafarnia, 2011), whereas others concluded 
no clinically relevant efficacy for the use of shockwave therapy on lateral elbow 
tendinopathy (Haake et al., 2002; Speed et al., 2002; Buchbinder et al., 2005; 
Staples et al., 2008). 
 
The advantages of shock wave therapy are the non-invasiveness (avoidance of 
surgery), low associated complication rates (e.g. minimal petechial skin hemorrhage, 
minor local swelling and hematoma), and efficacy for indications refractory to other 
standards of practice (e.g. osseous non-union); flat learning curve; and cost-
effectiveness (Mittermayr et al., 2013). 
 
2.10.4 Types of Shockwave 
There are various types of shockwave therapy: focused shockwave therapy, 
unfocused or radial shockwave therapy, as well as de-focused shock wave therapy.  
 
Extracorporeal shockwave therapy originally used focused shockwaves (Van der 
Worp et al., 2011).  Focused shockwave therapy is called focused because a 
pressure field is generated that converges in the adjustable focus at selected depth 
in body tissues where maximal pressure is reached, (Van der Worp et al., 2013).  
Focused shock waves are generated by electro-hydraulic, electromagnetic and 
piezoelectric devices.  The acoustic energy is concentrated in a well-defined point of 
the target tissue, with varying focal volume, depth of penetration, level of Energy Flux 
Density (EFD) and total energy administered (Romeo, Lavanga and Sensone, 2013).  
The use of focused shock waves, especially when high energy levels are used, 
requires accurate identification of the area to be treated.  This allows the most 
favourable therapeutic effect, and avoids damage to the surrounding tissue.   For this 
purpose, radiographic or ultrasound guidance is necessary.  In the treatment of easily 
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located soft tissue injuries, patient feedback is usually sufficient to localise the area 
(Romeo, Lavanga and Sensone, 2013).   
 
Unfocused or radial shockwave is a form of extracorporeal shockwave.  It refers to a 
diverging pressure field which has a more superficial effect on tissues than focused 
shockwaves which reach a maximal energy in the focus that is located deeper into 
the tissue (Van der Worp et al., 2013).  Radial shockwave or pressure waves are 
produced by pneumatic generators, whose physical properties significantly differ from 
focused shock waves.  
The linear pressure, low energy values, relatively low velocity of propagation and, 
above all, the short duration of the rise time, differentiate radial waves from focused 
shock waves.  In radial shock wave generators, the compressed air strikes a bullet 
contained in a cylinder.  At the top of this cylinder is the applicator, which is in contact 
with the skin during treatment.  The energy produced by the pressure wave is highest 
at the skin surface, diverging and weakening as it penetrates deeper (Romeo, 
Lavanga and Sansone, 2013). 
 
De-focused shock waves are generated by electromagnetic and electro-hydraulic 
devices that convert the acoustic wave into planar or into de-focused (soft-focused) 
waves, which retain the same physical characteristics, but deliver the energy to a 
larger surface area.  The depth of penetration will obviously be lower and therefore, 
the therapeutic use is limited to superficial lesions like cutaneous ulcers (Romeo, 
Lavanga and Sensone, 2013). 
 
2.10.5  Principle of Shockwave Generation 
Shockwave could be described as a large-amplitude compression wave, that was 
produced by an explosion, or by the supersonic motion of a body in a medium.   
Clinically useful shockwave is effectively a controlled explosion, and when it enters 
the tissues, it will be reflected, refracted, transmitted and dissipated like any other 
energy form (Ogden et al., 2001).  The energy content of the wave will vary and the 
propagation of the wave will vary with tissue type.  Just like an ultrasound wave, the 
shock wave consists of a high-pressure phase followed by a low pressure (or 
relaxation) phase.  When a shockwave reaches a 'boundary', some of the energy will 
be reflected and some transmitted (Watson, 2014). 
 
A shock wave is defined as an acoustic wave, at the front of which pressure rises 
from the ambient value to its maximum within a few nanoseconds.  Shockwaves are 
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characterised by high peak-pressure amplitudes (500 bar) with rise times of less than 
ten nanoseconds, a short lifecycle (<10 ms), and a frequency spectrum ranging from 
16 Hz to 20 MHz, after reaching the positive peak the pressure rapidly drops to 
negative values within microseconds (Ioppolo et al., 2014). 
 
Both the positive and the negative phase of a shockwave have an effect on interface 
between tissues with different density (acoustic impedance).  During the positive 
phase shock waves with high pressure may hit an interface, leading to reflections, or 
they may pass and gradually become absorbed.  The negative (tensile) phase of the 
shock wave causes cavitation at the tissue interfaces.  During cavitation air bubbles 
are formed as a result of the negative pressure which implodes with high speed 
generating a second wave of shock waves or micro jets of fluid.  This causes the 
direct (physical) and indirect (biological) effects of the shockwaves on the treating 
tissue (Ioppolo et al., 2014).  
 
2.10.6 Techniques of Shockwave Generation 
Shock waves are generated through four techniques, these are electromagnetic, 
electrohydraulic, piezoelectric or electro-pneumatic (Ioppolo et al., 2014).  
 
The electromagnetic technique involves the electric current passing through a coil to 
produce a strong magnetic field, which induces a high current in the opposing 
membrane.  This current accelerates the metal membrane away from the coil to the 
100 000-fold of gravity, thus producing an acoustic impulse in surrounding water.  
The impulse is focused by an acoustic lens to direct the shock wave energy to the 
target tissue.  The lens controls the focus size and amount of energy produced within 
the tissue (Ioppolo et al., 2014). 
 
The electrohydraulic technique represents the first generation of orthopedic 
shockwave machines.  Electrohydraulic shock waves are high-energy acoustic 
waves generated by an underwater explosion with high-voltage electrode spark 
discharge, and the acoustic waves are then focused with an elliptical reflector and 
targeted at the diseased area to produce a therapeutic effect (Wang, 2012).  The 
electrohydraulic technique incorporates an electrode submerged in a water-filled 
housing compartment comprised of an ellipsoid, and the patient interface.  The 
electrohydraulic generator initiates the shock wave by an electrical spark produced 
between the tips of the electrode.  Vaporization of the water molecules between the 
tips of the electrode produce an explosion thus creating a spherical shock wave.  The 
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wave is then reflected from the inside wall of a metal ellipsoid to create a focal point 
of shock wave energy in the target tissue.  The size and shape of the ellipsoid control 
the focal size and the amount of energy within the target (Ioppolo et al., 2014). 
 
The piezoelectric technique involves a large number (usually > 1 000) of piezo 
crystals mounted in a sphere and receives a rapid electrical discharge that induces a 
pressure pulse in the surrounding water steepening to a shockwave. The 
arrangements of the crystals cause self-focusing of the waves towards the target 
centre, and lead to extremely precise high-energy within a defined focal volume 
(Wang, 2012). 
 
The electro-pneumatic technique is generated through the acceleration of a projectile 
inside the hand piece of the treatment device and then transmitted radially from the 
tip of the applicator to the target zone.  Radial shockwaves show a lower peak 
pressure and a considerably longer rise time than focused shockwaves; the focal 
point is not centered on the target zone as occurs in focused shock wave, but on the 
tip of the applicator (Ioppolo et al., 2014).  
 
2.10.7  Parameters of Shockwave Therapy 
The most important parameters of shockwave therapy for the treatment of 
musculoskeletal disorders include pressure distribution, energy flux density, total 
acoustic energy and frequency (Wang, 2012). 
 
The energy flux density is the energy at the focal point of the shock wave per impulse, 
and is recorded as joules per area.  The effective total energy of a treatment is 
defined by the number and energy flux density of the single impulses and by the 
geometrical measurement of the focal point.  Focused shock waves have a high 
(>0.2 mj /mm) energy flux density. The energy flux density is one of the most 
important parameters of shock wave therapy in the treatment of musculoskeletal 
disorders (Ioppolo et al., 2014).  The number of shocks, interval between shocks, 
number of treatments, and interval between treatments are additional parameters 
that can determine the therapeutic response (Ioppolo et al., 2014).  The frequency of 
shock wave therapy which is measured in hertz, is the number of shockwaves 





2.10.8 Biological Effects of Shockwave 
The mechanism by which an acoustic signal is converted into a biological reaction 
was not fully understood.  Potential mechanisms include initial neovascularization 
with ensuing durable and functional angiogenesis.  Furthermore, recruitment of 
mesenchymal stem cells, stimulated cell proliferation and differentiation, and anti-
inflammatory and antimicrobial effects as well as suppression of nociception are 
considered important factors of the biological responses to therapeutic shockwaves 
(Hayashi et al., 2012). 
 
2.10.8.1 Tissue regeneration 
Extracorporeal shockwave therapy induces tissue regeneration and facilitates 
tendon healing after trauma, as well as significantly increasing neovascularization 
and reduction of adhesion formation (Orhan et al., 2004).   
 
Shockwave microscopically causes interstitial and extracellular biological 
responses and tissue regeneration (Notarnicola and Moretti, 2012).  It is possible 
to hypothesise that mechanotransduction is the basis of the biological response to 
a shockwave impulse.  Mechanotransduction is the mechanism by which reactive 
cells recognise and respond to mechanical stimulation, converting physical forces 
into biochemical signals. Mechanotransduction stimulate extracellular matrix 
binding proteins and the nucleus via the cytoskeleton resulting in response leading 
to tissue regeneration.  Recent histologic, biochemical, and immunologic basic 
science studies have greatly advanced the understanding of how shockwaves 
affect tissue regeneration. These effects include enhanced neovascularity, 
accelerated growth factor release, selective neural inhibition, osteogenic stem cell 
recruitment, and inhibition of molecules that play a role in inflammation (Ioppolo et 
al., 2014).  
 
2.10.8.2 Release of growth factors  
A study by Notarnicola and Moretti, (2012) has demonstrated that shockwave 
treatment can increase the number of neovessels at the normal tendon-bone 
junction, through the release of growth factors and some other active substances.  
The first evidence that extracorporeal shock wave promoted tendinitis repair 
coincides with an increase in TGFb1 and IGF-I.  These growth factors have been 
found to up-regulate extracellular matrix biosynthesis by tenocytes.  It has been 
proposed that these increased mitogenic and anabolic responses of tendon tissue 
can be responsible for the clinical success of shockwave treatment in resolving 
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tendon pathologies.  Tenocytes can respond to mechanical stimulation by 
increasing TGF-b1 gene expression.  These findings seem to indicate that tendon 
tissue can convert shockwave stimulation into biochemical signals via release of 
growth factors (TGF-b1 and IGF-I) for tendonitis repair. 
 
2.10.8.3  Pain relief 
Healthy tendons are relatively avascular.  Neovascularization and the 
accompanying neonerves have been hypothesized to be the source of pain in 
chronic tendinopathy (Tol, Spiezia and Maffuli, 2012).  Shockwave increases 
neovascularization which stimulates the formation of neonerves which could 
explain the reason for the initial increase in pain with shockwave therapy.  When 
the initial treatment pain subsides there is secondary analgesia. 
 
Pain relief with extracorporeal shockwave might work by means of hyper 
stimulation analgesia; overstimulation of the treated area would lead to a 
decreased transmission of signals to the brainstem (Van der Worp et al., 2013). 
 
2.10.8.4 Destruction of calcifications 
It has been proposed that the therapeutic effect of shockwave on calcific 
tendinopathies is that increasing pressure within the therapeutic focus causes 
fragmentation and cavitation effects inside amorphic calcifications and leads to 
disorganization and disintegration of the deposit (Mouzopoulos et al., 2007). 
 
2.10.8.5  Bone remodelling 
The effect of shock waves on bony tissue is thought to occur primarily at the 
interface between cortical and cancellous bone.  It is thought that acoustic 
streaming causes cavitation and increases cell permeability allowing increased 
vascularity and bony regeneration.  More specifically, an increase in stromal cells 
seems to allow osteogenesis.  Additionally, the increase in osteoprogenitor cells 
coupled with local increase in growth factor, neovascularization and protein 
synthesis suggests that shockwaves can improve the tissue environment for 
healing to occur (Thigpen, 2011).  Animal experiments showed stimulated fracture 
healing, and histological investigations confirmed the influence of shockwaves on 





2.10.8.6 Lubricin production 
Lubricin is a lubricating glycoprotein that facilitates tendon gliding, and is 
upregulated by mechanical as well as biochemical stimuli.  In a study conducted 
by Zhang et al., (2011) extracorporeal shockwave was found to increase lubricin 
expression in both low-dose and high-dose. Lubricin expression generally 
increased with an increasing dose of extracorporeal shockwave.  
 
Results showed that extracorporeal shockwave stimulated endogenous lubricin 
production in tendons and septa in the rat hind limb, reflected in the percentage of 
cells containing lubricin and the percentage of the extracellular matrix displaying 
the presence of the mucinous glycoprotein.  Being a form of mechanical loading, 
extracorporeal shock wave stimulates the upregulation of lubricin, pointing to the 
fact that this form of physical stimulus induces excessive expression of lubricin in 
vivo (Zhang et al., 2011). 
 
This result provides a basis for the hypothesis that increased lubricin deposits in 
tendons and septa following extracorporeal shock wave contribute to the 
beneficial effects of extracorporeal shockwave by facilitating movement 
macroscopically among gross structures, as well as microscopically among 
collagen fascicles.  Increased lubricin expression may contribute to the beneficial 
effects of extracorporeal shockwave in providing pain and symptom relief in 
musculoskeletal disorders by decreasing erosive wear (Zhang et al., 2011).  
 
Experimental results show that extracorporeal shockwave significantly stimulated 
the ingrowth of neovascularization associated with increased expressions of 
angiogenic growth indicators in tendon, bone and tendon-bone interface.  
Neovascularization may play a role in the improvement of blood supply and 
healing of the tendon.  There is a close relationship between the decrease in 
Substance-P release, with consecutive pain reduction when applying shockwave 
treatment to the tendon insertion where there is pathology (Notarnicola and 
Moretti, 2012). 
 
2.10.9  The use of Shockwave Therapy in Tendinopathy 
Extracorporeal shockwave treatment is generally used for soft tissue injuries such as 
the following tendinopathies: plantar fasciitis, lateral elbow, patellar and Achilles 
tendinopathy (Maffuli et al., 2010).  Low-energy (radial) shockwave therapy 
stimulates soft tissue healing and inhibits pain receptors.  The rationale for its clinical 
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use is stimulation of soft tissue healing and inhibition of pain receptors.  It is widely 
used for soft tissue pathology.  Effects after repetitive application were significantly 
greater than after single application.  Low-energy shockwave therapy also enhances 
angiogenesis (Maffuli et al., 2010). 
 
2.10.10 Conclusion 
In 1929, Dr Kellog Speed (professor of orthopaedic surgery) came to the conclusion: 
‘‘The aetiology of tennis elbow is various, its pathology is obscure and its cure is 
uncertain’’, and in many ways, this holds true today.  
 
Advances have been made in our understanding of the histopathology of the 
condition, but it remains a challenge why these changes occur and why some cases 
become recalcitrant.  Despite a multitude of treatment options, there remains lack of 
consensus regarding best practice (Erickson and Hall, 2015). 
 
The most effective and consistent management strategy for chronic lateral elbow 
tendinopathy remains unknown.  Both failed conservative and surgical management 
of chronic lateral elbow tendinopathy is motivation for further research.  Radial 
shockwave therapy could be an alternative conservative treatment if proven effective.  
It is a safe procedure and there are not many known adverse side-effects of 





3. METHODOLOGY          
 
3.1  STUDY DESIGN 
A non-randomised, single-blinded, placebo controlled study.  
 
3.2  POPULATION AND SAMPLING 
The following section describes the source and selection of participants for this 
clinical trial.  
 
3.2.1  Source of Participants 
Patients with chronic lateral elbow tendinopathy from the Virgin Active gym in 
Krugersdorp, tennis clubs (Noordheuwel as well as Krugersdorp) and industry 
(Plascon) were invited to participate in this study.  Patients were also referred from 
general practitioners, orthopaedic surgeons as well as other physiotherapists in the 
area.   
 
3.2.2  Sample Selection 
The calculation of the sample size (refer to appendix 9) was done with the power set 
at 90%, the standard deviation at 15, the effect to be detected at 15 and the alpha at 
5%; n (per group) was calculated at 35 (Whitley and Ball 2002). 
 
A sample of 41 patients with lateral elbow tendinopathy was recruited for the study.  
The study was conducted at the Noordheuwel medical centre (a private medical 
setting) where the shockwave machine was located. There were rooms for general 
practitioners, a physiotherapy practise, a pathology practise and an emergency 
procedure room in the centre.  Systematic sampling was used to allocate patients to 
the intervention and control group, by including all participants in the study with 
lateral elbow tendinopathy that met the inclusion criteria.  Recruited patients were 
systematically assigned to a radial shockwave treatment group (intervention), or a 
placebo treatment (control) group through a computer-generated list, created by a 
computer programmer. The researcher was blinded to the systematic sampling 
process. 
 
3.3  INCLUSION CRITERIA 
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▪ Subjects over the age of 18, presenting with chronic lateral elbow tendinopathy 
for at least three months. 
▪ Tenderness near the lateral epicondyle over the origin of the extensor carpi 
radialis brevis and extensor digitorum communis muscles. 
▪  Pain with wrist extension against resistance. 
 
▪ Functional impairment of the upper limb due to symptoms in the elbow. 
 
3.4  EXCLUSION CRITERIA 
▪ Patients with pacemakers.  
▪ All other known causes of elbow pain such as: elbow arthritis, neurological 
pathology such as carpal- or cubital tunnel syndrome and radial nerve 
entrapment, previous elbow surgery, elbow fracture or dislocation.  
▪  Cervical spondylosis.  
▪  Severe systemic illness, rheumatologic disease, malignancies.  
▪  Pregnancy.  
▪  Previous shockwave treatment for their lateral elbow tendinopathy.  
▪  Patients on anti-coagulation therapy.  
▪  Patients currently using NSAIDS. 
 
3.5  VARIABLES 
3.5.1  Independent Variable 
Radial shockwave treatment.  
 
3.5.2  Dependant Variable   
Pain, grip strength and upper limb function. 
 
3.5.3  Extraneous Variable 
Patients using NSAIDS or other treatment options, such as cortisone injections or 
platelet rich plasma injections prior to the clinical trial. 
 
3.6  OUTCOME MEASURES 
            The demographic information including age, gender, smoking, involvement of the do-          
            minant or non-dominant arm, work that affects upper limb function, as well as sport  
            that affects upper limb function was completed by the participants using the     
            demographic data sheet (appendix 16). 
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The Visual-analog scale (VAS) (appendix 10) is a psychometric response scale that 
can be used in questionnaires.  This measuring instrument can be used for the 
subjective measurement of pain.  Pain assessed with the VAS scale is a 
unidimensional measure of pain intensity.  Participants express their pain intensity by 
marking a position along a continuous line between two end-points on a 100 mm 
horizontal line.   It usually takes less than one minute to complete the measurement.  
Scoring on the VAS is determined by measuring the distance (mm) with a ruler on 
the 100 mm line between the “no pain” and the patient’s mark, providing a range of 
scores from 0 – 100mm.  According to research the visual analogue scales metrical 
characteristics are superior to discrete scales, therefore a wider range of statistical 
methods can be applied to the measured parameters.  The characteristic of the 
instrument is based on calculated intra-class correlation coefficients (ICC) of 0.97 for 
acute pain, and Cronbach’s alpha varies depending on the studies from 0.79 to 0.91 
(Janikowska and Chomiuk, 2013).  The VAS scale was used in this study to assess 
pain before physical assessment and treatment with the Mc Gill Pain Questionnaire 
Short Form and during the Thomsen provocation test at baseline, as well as at one 
week and three month’s follow up. 
 
The Thomsen provocation test (appendix 10) was used when resistance was applied 
for wrist extension; the pain experienced during this test was rated using the VAS 
scale.  This test was done with the patient’s shoulder in 60 degrees’ flexion; full 
elbow extension; forearm pronation and the wrist in 30 degrees’ extension (through 
observation). The physiotherapist then applied pressure to the dorsum of the second 
and third metacarpal bones against extension and radial deviation to resist the 
extensor carpi radialis brevis, and longus muscles (Rompe et al., 2004). 
 
The McGill Pain Questionnaire Short Form (MPQ-SF) (appendix 7) was used to 
evaluate subjective pain.  The Pain Rating Index (PRI) contains 15 words, 11 
sensory and four affective, one item tests Present Pain Intensity (PPI), and another 
item test pain with the visual analogue scale (VAS).  Each word is rated on a four -
point scale from 0 (none) to 3 (severe).   Scores for the questionnaire ranged from 0 - 
45 on the PRI, from 0 - 5 on the PPI totaling 50, and between 0 - 100 mm on the VAS 
scale.  The MPQ-SF is a reliable (retest over three to seven days indicated that 
respondents chose the same words in the Pain Rating Index as well as the Present 
Pain Intensity) and a valid (the respondents’ tendency to use all 20 subclasses of 
pain words was consistent when retested) instrument that is quick and easy to use 
(Burckhardt and Jones, 2003).  
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The Disabilities of the Arm, Shoulder and Hand (DASH) (appendix 4) Outcome 
Measure is a 30-item, self-report condition specific questionnaire.  The questionnaire 
includes 21 physical function items, six symptom items, and three social/role function 
items.  It also consists of two optional four-item modules, one is for the working 
population and the other is for athletes or performing artists.   Each item of the DASH 
is scored on a five-point scale (1 - 5).  Lower scores reflect less disability and higher 
scores reflect more disability.  The DASH was developed to measure physical 
symptoms as well as physical function in patients with upper limb musculoskeletal 
dysfunctions, and was published in 1996.   
This tool was designed by the Institute for Work & Health and the American Academy  
of Orthopaedic Surgeons (AAOS), and supported by the American Association for  
Hand Surgery, the American Orthopaedic Society for Sports Medicine, the American  
Shoulder and Elbow Surgeons, the Arthroscopy Association of North America, and 
the American Society of Plastic and Reconstructive Surgeons and the American  
Society for Surgery of the Hand, (Janikowska and Chomiuk, 2013).  The DASH is a  
reliable, valid and responsive measuring tool and can be used for research and 
clinical purposes with a Cronbach’s alpha of 0.96-0.97, (Finch et al., 2002).  The 
DASH can be used for patients with one or more upper extremity musculoskeletal 
dysfunctions.   
The Quick DASH is a shortened version of the DASH Outcome Measure.  Instead of               
30 items, the Quick DASH consists of 11 items.  Scoring is divided into the two 
components: the disability/symptom section, consisting of 11 items; after scored 1 –5; 
and the optional high-performance sport/music or work modules with four items, 
scored 1 - 5.  At least 10 of the 11 items must be completed to calculate the score.  
This tool was developed to measure disability; hence the scaling was ranked from 0 
indicating lowest disability to 100 indicating highest disability.  Both instruments 
(DASH and Quick DASH) are reliable, valid and responsive and can be used for 
research and clinical purposes.  The tools are characterised by rating of intra - class 
correlation coefficient on 0.94 and Cronbach’s alpha also on 0.94 (Janikowska and 
Chomiuk, 2013).  The Quick DASH was used in this study, as it is shorter but also 
reliable (ICC (2.1) = 0.90 and valid Pearson r > 0.70) (Mintken, Glynn and Cleland, 
2009; Beaton, Wright and Katz, 2005).  
 
The most common functional limitation in LET is pain on gripping, and this can be 
measured as pain-free grip strength, which is a reliable and valid measure that is 
more sensitive to change than maximal grip strength where the patient is asked to 
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grip a dynamometer until the onset of pain.  Three tests are done with one-minute 
between each, the mean is then calculated of the three measurements (Bisset and 
Vicenzino, 2015).  For the purposes of this study three repetitions of pain-free grip 
strength were measured with the Jamar dynamometer, and using the mean of the 
three scores.   
 
The Jamar dynamometer (appendix 12) is often used in studies as an objective 
measuring instrument  to measure grip strength, the pressure being registered in 
kg/cm2 (Staples et al., 2008; Rompe et al., 2004).  It is calibrated before use, and is a 
valid and reliable measuring tool (Peters et al., 2011).   
 
Measurements were taken at baseline, one-week and three months’ post treatment, 
for the intervention and control groups.  The differences in values at baseline and 
follow up were compared between the two groups.  The data collected by these 
outcome measures were statistically analysed by the principal researcher, the 
second supervisor and a statistician to evaluate the outcome of the intervention. 
 
3.7 PROCEDURES 
3.7.1  Pilot Study 
A pilot study with seven participants (four men and three women) was done before 
the clinical trial was undertaken. These patients all received radial shockwave 
therapy as per protocol to test procedures and methods before commencing the main 
study.  The aim of the pilot study was thus to test the amount of time it took to 
complete the outcome measures, to test the operation of the shock wave machine, 
and the administration of shock wave treatment (intervention and placebo); and to 
train the research assistants regarding the aforementioned.  The outcome of the pilot 
study was that the main study was feasible in terms of design and procedures.  The 
pilot study confirmed that the main study could be carried out as planned. 
 
3.7.2  Main Study 
The main study consisted of 41 participants (21 men and 20 women), with a 
diagnosis of lateral elbow tendinopathy who all met the inclusion criteria.  Treatment 
started within seven days of recruitment. The participants read the information 
document and signed the consent form (appendix 2).  They completed the McGill 
pain Questionnaire including the VAS scale, and the quick-DASH questionnaire that 
assessed upper limb function.   
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The researcher completed the physical examination which included palpation of the 
elbow to localise the pain; the Thomsen provocation test rated with the VAS scale to 
assess pain intensity, and three measurements of maximal pain free grip-strength 
with the dynamometer, using the average of the three measurements as the final 
score. 
 
The two physiotherapists (research assistants) carrying out the intervention and 
placebo treatment was briefed about the treatment protocol during the pilot phase.  
Information regarding the dosage, technique used as well as the specific eccentric 
exercise programme (see appendix 8), and placebo treatment was demonstrated and 
provided in hard copy to ensure standardization.  The following was discussed with 
the research assistants and demonstrated: treatment of the placebo group included 
fitting a reflective cap on the shockwave applicator.  The treatment area was 
localized by a clinical focusing method in which, through palpation, the shockwaves 
were administered to the most painful area with verbal feedback from the patient.  
The dosage of radial shockwave followed the protocol of the Klimatur shockwave 
therapy device.  The setting on the machine was: epicondylitis humeri radialis (ECRL, 
ECRB and EDC).  The dosage parameters were 2 000 shots, 45% pressure and a 
frequency of 8HZ (8 shots per second).  The low energy RSW was done without local 
anaesthetic.  The participants received three treatments in total; one treatment per 
week, for three consecutive weeks. The treatments consisted of radial shockwave or 
placebo treatment, as well as an eccentric exercise program (see appendix 8) that 
included stretching of the wrist extensors with a straight elbow, resisted eccentric 
wrist extension with a theraband, and resisted eccentric wrist pronation with a 
theraband.  The research assistants advised the participants of both the groups to 
avoid pain provoking activities.  Radial shockwave was the intervention tested in 
conjunction with eccentric exercises, as it is considered the best long-term solution 
for LET.  Eccentric exercise was added to the radial shockwave treatment to find the 
best treatment option for LET, and to give participants some form of treatment if they 
received placebo treatment.  All outcomes measures were retested one-week post 
treatment, as well as three month’s post treatment.  The researcher captured and 
analysed the data post-intervention. 
 
3.8 DATA ANALYSIS 
The outcomes measures used for data collection were: VAS - Thomsen, VAS – SF - 
MPQ, Quick-DASH and Jamar dynamometer.  
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The types of data collected from these outcomes measures were categorical with a 
nominal scale of measure (gender, arm dominance, smoking, effect of work and 
sport on upper limb function), and an ordinal scale of measure (McGill total values, 
Quick-DASH total, Q-DASH work, Q-DASH sport), and categorical with a ratio scale 
of measure (Thomson’s VAS, McGill VAS and grip strength). 
 
The statistical tests that were used for categorical data analysis was the Fisher Exact 
test (nominal scale) as well as the Mann Whitney U test (ordinal scale). The 
statistical test used for continuous data was the Mann Whitney U test. 
 
This data was statistically tested and analysed by the researcher with assistance of 
the second supervisor and statistician, using the Statistica (Version 12) programme.  
The data was considered as significant if the p values were 0.05 or less.  The data 
was tested for normal distribution.  It was taken into consideration that the data was 
skew and unpaired. 
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Table 3.1: Data Analysis 
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3.9  ETHICS 
Ethical clearance was procured from the Human Research Ethics Committee of the 
University of the Witwatersrand (appendix 5). 
 
Permission was aquired from the owner/shareholder of Noordheuwel Medical Centre 
to conduct this research project on the premises (appendix 3).  
 
All patients were treated in accordance with the Declaration of Helsinki (appendix13). 
The participants received an information form (appendix 1) explaining the procedure, 
benefits and risks of treatment, and signed a consent form (appendix 2). 
 
The assessment forms were coded according to the computer generated list of 
numbers.  The coded list of names was kept separately from the assessment forms. 
 
Results of the study will be made available to the public through journal publication, 
and participants will have access to the results on request. 
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CHAPTER FOUR 
4. RESEARCH RESULTS 
 
4.1 INTRODUCTION 
This chapter presents the results as set out by the objectives of the study. 
 
The intervention group is represented as G1, and the control group is represented as 
G2 for the purposes of this study. 
        















                             
In the Q-DASH Questionnaire there was an optional module for sport and work which 
the participants completed if it was applicable to them, however the activities of daily 
living were a compulsory module, which explains the smaller response rate for the 
optional modules.  
  
4.1.1  Demographic Information 
4.1.1.1 Age  














            
*p≤0.05 (Mann-Whitney U test) 
 
Table 4.1 above shows that the groups were comparable by age. 
 
4.1.1.2 Gender, Arm dominance, Smoking distribution, Work and Sport characteristics 
Table 4.2 presents the gender, arm dominance, smoking distribution, work and sport 
characteristics of the study participants. 
 
Table 4.2: Gender, Arm Dominance, Smoking Distribution, Work and Sport 
Characteristics 











25th 42.00 46.25 
50th 46.00 49.00 
75th 54.00 60.25 
Group Frequency (%) p-value* 
Gender Male Female 
0.22 Intervention (n=21) 13 (31.7%) 8 (19.5%) 
Control (n=20) 8 (19.5%) 12 (29.3%) 
Arm dominance Dominant arm Non-Dominant arm 
1.00 Intervention (n=21) 14 (34.1%) 7 (17%) 
Control (n=20) 13 (31.71%) 7 (17.1%) 
Smoking Smoking Non-Smoking 
0.66 Intervention (n=21) 2 (4.9%) 19 (46.3%) 
Control (n=20) 3 (7.3%) 17 (41.5%) 
 
Work affects upper limb 
function 
Work does NOT affect 
upper limb function 
 
Intervention (n=21) 14 (34.1%) 7 (17.1%) 
3.5 
Control (n=20) 10 (24.4%) 10 (24.4%) 
 
Sport affects upper limb 
function 
Sport does NOT affect 
upper limb function 
 
Intervention (n=21) 12 (29.3%) 9 (22.0%) 
1.00 
Control (n=20) 12 (29.3%) 8(19.5%) 
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Table 4.2 above reports on the demographic information of the participants. 
Participants also reported on the effect that sport and their occupation had on upper 
limb function. 
 
In Table 4.2 above no statistical significance was found between the aforementioned 
groups, thus the type of work that the participants were doing did not affect their 
upper limb function in the presence of chronic lateral elbow tendinopathy.  No 
statistical significance was found for the intervention and control group for the sport, 
thus upper limb function during sporting activities was not affected by LET. 
 
4.1.2  Pain Levels 
The first objective of the study was to compare pain levels of the intervention and 
control group at baseline, one week, as well as three months’ post treatment in 
patients with chronic lateral elbow tendinopathy. 
 
The pain outcomes used in this study were: 
▪ The Thomsen VAS scale. 
▪ The McGill Pain Questionnaire VAS scale. 
▪ The McGill Questionnaire-total score (refer to section 3.6) 
 
4.1.2.1 Pain levels: Thomsen provocation test (VAS scale) 
Table 4.3 presents the pain levels of the study participants measured with the 
Thomsen provocation test (VAS scale). 
 
Table 4.3 Pain Levels: Thomsen Provocation Test (VAS Scale) 





















25th 3.00 2.5 1.00 2.00 0.00 0.00 
50th 5.00 5.00 2.00 4.00 1.00 0.00 
75th 7.00 6.5 4.00 5.00 2.00 2.00 
p-value* 0.86 0.15 0.77 
*p≤0.05 (Mann-Whitney U test) 
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In Table 4.3 above no statistical difference was found between the intervention and 
control group using the Thomsen provocation test VAS scale. 
 
4.1.2.2 Pain levels: McGill Pain Questionnaire (VAS scale) 
Table 4.4 presents pain levels of the study participants measured with the McGill 
Pain Questionnaire (VAS scale). 
 
 
Table 4.4: Pain Levels: McGill Pain Questionnaire (VAS Scale) 
McGill VAS Scale 
 
Percentile 



















25th 3.0 3.5 1.0 1.0 0.0 0.0 
50th 4.0 5.0 2.0 2.0 1.0 1.0 
75th 6.0 6.0 3.0 4.0 2.0 2.0 
p-value* 
 
0.38 0.18 0.53 
*p≤0.05 (Mann-Whitney U test) 
 
In Table 4.4 above no statistical difference was found between the intervention and 
control group using the McGill Pain Questionnaire (VAS scale). 
 
4.1.2.3 Pain levels: McGill Pain questionnaire (total score) 
Table 4.5 presents the pain levels of the study participants, measured with the McGill 
Pain Questionnaire (total score). 
 
Table 4.5: Pain Levels: McGill Pain Questionnaire (Total Score) 





















25th 6.0 5.5 2.0 3.0 0.0 0.0 
50th 12.0 9.0 4.0 9.0 1.0 2.0 
75th 19.0 19.5 7.0 16.0 4.0 6.0 
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p-value* 0.83 0.12 0.94 
*p≤0.05 (Mann-Whitney U test) 
 
In Table 4.5 above no statistical difference was found between the intervention and 
control group using the McGill Pain Questionnaire (Total Score). 
 
 4.1.3  Grip Strength 
The second objective of the study was to compare grip strength between the 
intervention and control group at baseline, one week, as well as three months’ post 
treatment in patients with chronic lateral elbow tendinopathy. 
 
Table 4.6 presents grip strength of the study participants measured with a 
dynamometer. 
 






















25th 21.0 19.5 25.0 21.0 28.0 26.0 
50th 31.0 24.0 45.0 26.0 47.0 32.0 
75th 47.0 45.5 52.0 45.0 55.0 49.0 
p-value* 0.466 0.57 0.33 
*p≤0.05 (Mann-Whitney U test) 
 
In Table 4.6 above no statistical difference was found between the intervention and 
control group for grip strength. 
 
4.1.4  Upper Limb Function 
The third objective of the study was to compare upper limb function between the 
intervention and control group at baseline, one week, as well as three months’ post 
treatment in patients with chronic LET. 
 
The upper limb function outcome measures used in this study were: 
▪ The Quick-DASH (Disabilities of the Arm, Shoulder and Hand) questionnaire- 
activities of daily living module, (as referred to in section 3.6). 
54 
▪ The Quick-DASH questionnaire, work-module. 
▪ The Quick-DASH questionnaire, sport-module. 
 
4.1.4.1 The Quick-DASH Questionnaire (A.D.L) activities of daily living module  
Table 4.7 presents upper limb function of the study participants measured with the 
Quick-DASH questionnaire. 
 
            Table 4.7: Upper Limb Function Measured with the Quick-DASH   























25th 27.0 45.0 9.0 14.0 0.0 2.0 
50th 39.0 52.5 16.0 34.0 5.0 16.0 
75th 48.0 59.5 30.0 41.0 16.0 23.0 
 *p-value 0.02 0.12 0.166 
*p≤0.05 (Mann-Whitney u test) 
 
In Table 4.7 upper limb function scores at baseline had better values for the 
intervention group compared to the control group.  However, there was no statistical 
difference found in the Q-DASH total between the intervention and control group at 
one week and three months’ post treatment, thus the intervention did not affect upper 
limb function. 
 
4.1.4.2 The Quick-DASH Questionnaire, work-module 
Table 4.8 presents upper limb function of the study participants measured with the 










Table 4.8: Upper Limb Function Measured with the Quick-DASH 
Questionnaire Work Module 





















25th 22.0 25.0 0.00 0.00 0.0 0.0 
50th 38.0 38.0 6.0 25.0 0.0 0.0 
75th 53.0 56.0 31.0 44.0 25.0 25.0 
*p-value 0.77 0.70 1.00 
*p≤0.05 (Mann-Whitney U test) 
 
In Table 4.8 above there was no statistical difference found between the intervention 
and control group for the Q-DASH work module. 
 
 4.1.4.3 The Quick-DASH Questionnaire, sport-module 
Table 4.9 presents upper limb function measured with the Quick-DASH questionnaire 
sport- module for the study participants. 
 























25th 25.0 37.5 0.0 0.00 0.0 0.0 
50th 40.5 75.0 25.0 25.0 0.0 25.0 
75th 84.5 75.0 38.0 38.0 25.0 28.0 
*p-value 0.48 0.91 0.08 
*p≤0.05 (Mann-Whitney U test) 
 
In Table 4.9 above there was no statistical difference found for the intervention and 
control group for the Q-Dash sport-module, thus upper limb function during sporting 






The intervention did not have any effect on the pain experienced by the participants; 
their grip strength nor their upper limb function due to the insignificant findings 
yielded from this study. 
 
Albeit this overarching finding, there were some changes seen in pain levels 































5.1  INTRODUCTION 
The primary aim of this study was to determine the effects of radial shockwave 
therapy in the treatment of chronic lateral elbow tendinopathy.  A non-randomised 
controlled trial was conducted for this purpose, consisting of an intervention and 
control group, comparing radial shockwave treatment to placebo treatment.  This 
chapter serves to discuss the results of this study.  
 
Lateral elbow tendinopathy is a chronic musculoskeletal condition causing significant 
pain, disability and loss of productivity in the work place (Janikowska and Chomiuk, 
2013).  This condition is easy to diagnose, but difficult to treat. There is no single 
intervention that has been proven to effectively manage this condition. This motivates 
further research with well-designed clinical trials.  The research hypothesis of this 
clinical trial states that there will be a significant improvement in pain, grip strength 
and upper limb function in patients with chronic LET treated with radial shockwave 
treatment, compared to patients receiving placebo treatment and vice - versa for the 
null hypothesis.  Chronic LET can be defined as lateral elbow tendinopathy persisting 
for three months and longer.  In this study the period that participants had chronic 
LET ranged from three months to ten years. 
 
5.2  DEMOGRAPHIC INFORMATION 
5.2.1  Age  
The age group presenting with chronic LET is middle aged individuals largely in their 
forties and fifties, with the highest occurrence of those aged between 45 -54 years.  
Studies conducted by Longo et al., (2012) as well as McMurtrie and Watts, (2012) 
showed the same findings regarding age distribution.  In this clinical trial the age of 
the participants was within these parameters. 
  
5.2.2 Gender 
Gender does not play a role in the presence of chronic LET as there is an equal 
distribution between men and women.  This was confirmed in studies by Longo et al., 
(2012) and McMurtrie and Watts, (2012).  In this clinical trial there was an equal 




5.2.3  Arm Dominance 
Although there was no significance found when comparing the groups for arm 
dominance, there was a higher occurrence for dominant arm involvement in this 
study, confirming the literature findings that arm dominance does affect the presence 
of chronic LET, and is more commonly seen in the dominant arm (Calfee et al., 2008; 
Longo et al., 2012). 
 
5.2.4  Smoking  
There is some controversy in the literature concerning the effects of tobacco smoking 
on chronic LET.  In a population study conducted by Shiri et al., (2006) consisting of 
4 783 participants, an association was found between tobacco smoking and LET.  
Tichener et al., (2013) also found that tobacco smoking could be associated with LET.  
Smoking could hinder the circulation to tendons, which not only predisposes these at 
risk tissues to injury but also slows or prevents their healing during the recovery 
period.  Ex-smokers are also at higher risk of LET suggesting that previous exposure 
to tobacco may have damaging effects on the vascular system (Shiri et al., 2006).  
Increased risk of LET among smokers may also be due to other lifestyle factors 
associated with smoking, such as an inactive lifestyle.  However, according to 
Walker-Bone et al., (2012) tobacco smoking was not an associated risk factor for 
lateral elbow tendinopathy. Smoking was not an associated risk factor that could be 
considered to contribute to the presence of LET in this study, as the majority of 
participants were non-smokers. 
 
To summarize the demographic information, chronic lateral elbow tendinopathy is 
common amongst middle-aged individuals, ages ranging between 45 - 54 with men 
and women being equally affected. The dominant arm is more commonly involved.  A 
clear conclusion cannot be made on the effects of smoking on LET from this clinical 
trial. 
 
5.3 OUTCOMES MEASURES 
In some studies, radial shockwave treatment is no more effective than placebo in 
relieving pain, improving grip strength and upper limb function, such as a study 
conducted by Chung, Wiley et al., (2005) consisting of sixty participants.   The results 
of their study did not support the efficacy of shockwave treatment combined with a 
stretching programme.  A study that had a similar outcome was conducted by 
Melikyan et al., (2003), with the following outcomes measures: VAS, grip strength 
59 
and the DASH questionnaire, and the results of their study concluded that all patients 
improved significantly over time, regardless if they were in the shockwave or control 
group.   
 
Similar results to the current study was obtained by Staples et al., (2008) where they 
conducted a double-blinded RCT on 68 patients to determine whether ultrasound -
guided ESWT (in this study radial shockwave guided by clinical focusing was used), 
decreased pain and improved function in patients with LET.  The outcomes 
measures used were the VAS- scale for pain, DASH-Questionnaire for upper limb 
function as well as maximal pain-free grip strength using a Jamar dynamometer 
which correlates to the outcomes measures used in this study.  At baseline the 
treatment groups did not differ on demographic or clinical characteristics.  Both 
groups showed an improvement in almost all the outcome measures, but there were 
no differences between the groups indicating that the benefit of ESWT is likely to be 
small. However clinically there was no significance, and it may require a very large 
sample to demonstrate an effect. The methodology, outcomes measures, results and 
recommendation of Staples et al., (2008) is similar to this clinical trial. 
 
5.3.1 Pain Levels 
Some of literature has shown that shockwave treatment is not more effective than 
placebo or other treatments for relieving pain in LET (Bisset and Vicenzino, 2015; 
Weber et al., 2015). The results of nine placebo-controlled trials (1006 participants), 
in a 2005 Cochrane review by Buchbinder et al., concluded that shockwave 
treatment is not effective in reducing pain levels in LET.  Data from the Cochrane 
review as well as a study by Staples et al., (2008) found that compared with placebo, 
shockwave treatment induced no greater pain relief (MD - 8, 95% CI -17 to 3) at six 
weeks.  Similarly, the mean difference for pain on resisted wrist extension (Thomsen 
provocation test) at four to six weeks’ follow-up was not significantly different 
between shockwave treatment and placebo (MD - 15, 95% CI - 36 to 6).  This finding 
is supported by results of this study: there was no statistical difference found when 
pain levels were compared using the Thomsens’ provocation test, and the McGill 
pain Questionnaire - short form (MPQ - SF) (see page 60 results section).  There are 
similar studies with positive pain outcomes when comparing shockwave treatment to 
placebo such as studies conducted by Rompe et al., (2004) as well Pettrone and 
McCall, (2005). Two other studies that also concluded that shockwave was an 
effective treatment to reduce pain in LET was a study by Radwan et al., (2008) where 
they compared a single high - energy ESWT treatment to percutaneous tenotomy, as 
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well as a study conducted by Collins, Hildreth and Jafarnia, (2011) where they 
compared a single high-energy shockwave treatment to placebo.  These two studies 
both used high-energy shockwave that is a different type and dosage to radial 
shockwave which is low-energy shockwave.  There are contradicting results in the 
literature for the efficacy of shockwave treatment for chronic LET, thus optimal 
treatment parameters have not been established for the symptomatic relief of pain.  
 
No statistical change was observed in this study in pain outcomes with all measures 
used, whilst pain levels decreased in general when comparing one-week post 
treatment to three months’ post - treatment for both of the aforementioned outcomes 
measures as seen from the medians (tables 4.5-4.7).  The null hypothesis was 
retained as these results were statistically insignificant.  The intervention failed to 
significantly improve pain levels for both outcomes measures when compared to the 
control group.  
 
The most likely explanation of the improvements in both groups is the natural 
progression of the condition, whereby most patients with LET recover within one to 
two years irrespective of the treatment administered (De Smedt et al., 2007; Staples 
et al.,2008; Longo et al., 2012). 
 
The improvement in pain levels of the intervention and control group could be due to 
the “Hawthorne effect” which is the tendency of persons (the study participants) who 
are singled out for special attention (the shockwave or placebo treatment) to perform 
better (have better outcomes), (Portney and Watkins, 2009). 
 
The insignificant improvement in pain levels of the intervention group compared to 
the control group could be due to a sub-optimal dosage received by the intervention 
group because of the painful effect of the shockwave treatment on participants.  The 
applicator of the radial shockwave had to be moved around the painful area as some 
of the participants could not tolerate the full dosage of treatment using the clinical 
focusing method.  The control group could possibly have had a trigger point effect of 
the reflective-cap that was fitted to the applicator tip due to the pressure applied to 
the painful area by the research assistants. 
 
The patient’s pain relief could be due to a combination of the treatment (intervention) 
specific agents as well as non-treatment specific agents such as spontaneous 
remission, conditioning, motivation, expectancy and other psychosocial agents 
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(Weber et al., 2015).  The therapeutic outcome of any medical treatment is 
influenced by the surrounding psychosocial context.  When a sham treatment (the 
placebo) is given, the patient believes it is effective and expects a clinical 
improvement.  The placebo effect, or response, is the outcome after the sham 
treatment.  The placebo effect is a psychobiological phenomenon that can be due to 
different mechanisms, including pavlovian conditioning as well as the expectation of 
clinical improvement (Benedetti et al., 2005). 
 
The placebo response or effect has often not been taken into consideration in basic 
research and particularly in clinical research (Enck, Benedetti and Schedlowski, 
2008).  Scientific evidence has demonstrated however, that the placebo effect 
originates from highly active processes in the brain that are mediated by 
psychological mechanisms such as expectation of clinical improvement, and 
pavlovian conditioning (Benedetti et al., 2005).  When an interaction (e.g., positive 
verbal suggestion by the therapist) creates the possibility of a reward (the therapeutic 
benefit of radial shockwave) certain cortical neurons become active.  These cells 
send direct excitatory glutamatergic inputs to dopaminergic cell bodies along with 
indirect inhibitory gamma amino butyric acid input.  The combination of these signals 
arriving at the dopaminergic neurons via direct and indirect pathways contributes to 
the probability of tonic activation (Enck, Benedetti and Schedlowski, 2008).  
Furthermore, during the expectation of reward it has been reported that neurons in 
the prefrontal cortex, nucleus accumbens, and the caudate-putamen display tonic 
activation.  This strongly suggests that placebo responsiveness depends on the 
functioning and efficiency of the reward system, and this could explain why some 
individuals respond to placebos whereas others do not.  Those who have a more 
efficient dopaminergic reward system would also be good placebo responders.  
 
The design of clinical trials in which treatment is tested against a placebo will be 
affected by the growing knowledge on the neurobiology of the placebo response.    
Researchers need to consider the significance of the placebo effect in clinical trials 
as it could have an effect on the significance of outcomes measures (Enck, Benedetti 
and Schedlowski, 2008). 
 
5.3.2  Grip Strength 
Both groups had an improvement in grip strength values and thus improvement in 
muscle strength from baseline to one week and three months’ post treatment (table 
4.6).  Although the intervention group had greater improvement in grip strength than 
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the control group at one week and three months’ follow up, grip strength for both 
groups did not yield a statistical significance indicating that the null-hypothesis was 
accepted.   
 
Literature confirming the results of this study for grip strength using a dynamometer 
includes the study of Melikyan et al., (2003).  Their conclusion was that all patients’ 
grip strength improved over time, regardless of treatment.  Chung et al., (2005) 
indicated in their study that the use of ESWT combined with a stretching programme 
was not effective for the improvement of grip strength in LET patients, and 
improvement in grip strength could occur over time.  Staples et al., (2008) concluded 
that their study did not find enough proof to support the use of ESWT to improve grip 
strength in LET patients, but it was rather due to the self-limiting nature of the 
condition that grip strength improved over time. These results confirmed that 
shockwave therapy did not have a positive effect on grip strength.  However, a study 
by Pettrone and McCall, (2005) yielded an improvement in grip strength. Their study 
concluded that low-dose shockwave therapy was effective for LET thus improving 
muscle strength.  This study like the other study’s also used a dynamometer to 
measure grip strength.  The difference however was the positioning of the participant 
when the measurements were done.  The current study included radial shockwave 
treatment as well as an eccentric exercise programme, whereas the other studies 
consisted of extracorporeal shockwave treatment only.  The one study that included 
a stretching programme was the study undertaken by Chung et al., (2005).  The 
majority of the aforementioned studies concluded that outcomes measures of LET 
such as grip strength improved over time irrespective of the treatment. 
 
Both groups received an eccentric exercise programme including a stretch of the 
wrist extensors with a straight elbow, eccentric wrist extensor and pronation 
strengthening with a theraband (appendix 8) that could have contributed to the 
improvement in grip strength.  In a review conducted by Raman et al., in (2012) their 
conclusion was that patients with LET who performed isotonic, eccentric, concentric, 
isometric, or isokinetic strengthening exercises could all have improvement in pain, 
grip strength, and disability over time.  The pain free grip strength could thus also 
have improved due to the decline in pain levels of both the groups, the positive 
changes could have been brought about by the eccentric strengthening of the tendon; 
and improvement over time due to the natural progression of LET. 
 
5.3.3  Upper Limb Function 
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Upper limb function was measured using the Quick-DASH questionnaire, the 
questionnaire comprises of three modules, the activities of daily living (A.D.L) module 
(compulsory module), work module (optional module), as well as the sport module 
(optional module).  
 
5.3.3.1 Activities of daily living module (Q - DASH) 
There was a statistical difference for the Q-DASH total at baseline with the 
intervention group being more functional than the control group.  Although there was 
a significant statistical difference at baseline, the results were insignificant for the Q-
DASH total after the intervention; both groups had an improvement in their daily 
function irrespective of the treatment they received.   
 
These results correlated with studies done by Melikyan et al., (2003) and Staples et 
al., (2008) where they both concluded that ESWT was not effective in the treatment 
of LET (using the Q-DASH as outcome measure), however Collins, Hildreth and 
Jafarna, (2011) found that a single ESWT treatment was effective for chronic LET 
(using the SF-Health Survey Questionnaire to determine upper limb function).  The 
improvement of upper limb function in the intervention and control group could be 
due to the same advice given to both groups by the treating physiotherapist, they 
were advised to modify their daily activities, to do less repetitive and loading activities, 
and to rest the affected upper limb.  The natural healing process of LET could also 
have brought about change in the intervention and control group over time in terms of 
daily function. 
 
5.3.3.2 Work Characteristics 
Although the groups were evenly matched, the frequency where work affected upper 
limb function was slightly higher (58.8%) compared to frequency where work did not 
affect upper limb function (41.5%), but the difference was not significant (table 4.2). 
 
The frequency of heavy duty work done by the participants in the intervention group 
was (24%) whereas the frequency of heavy duty work done by the control group was 
(5%).  The frequency of light duty work done by the participants in the intervention 
group was (76%) whereas the frequency of light duty work done by the participants in 
the control group was (95%) as per appendix 14. 
 
Shiri and Viikari-Juntura, (2011) stated that the prevalence for LET varies between 
0.3% and 13.5% in working populations which is higher than the prevalence of 1.3% 
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in the general population. Chronic lateral elbow tendinopathy has a substantial 
impact in the workplace, (Longo et al., 2012), and is most common in manually 
intensive occupations such as butchers, meat cutters, construction workers and 
automobile assembly workers (Walker-Bone, 2012). Productivity loss has been 
reported by inflicted workers with the length of sick leave due to LET being nearly two 
weeks (Shiri and Viikari-Juntura, 2011). Absenteeism in the working population (aged 
25 - 64) due to LET in the United Kingdom alone is estimated to cost £27 million per 
year using the 2012 global population statistics and median wage (Hopkins et al., 
2016).  Repeated medical visits are also costly as LET is recurrent (Hopkins et al., 
2016). Chronic lateral elbow tendinopathy can cause job changing in manually 
strenuous jobs (Shiri and Viikari-Juntura, 2011). 
 
Although the literature states that there is a significant relationship between physical 
work and LET (Walker-Bone et al., 2012), in this study the participants’ work did not 
have a statistically significant impact on LET which could possibly be due to the type 
of occupations of the participants’, as well as the limited amount of study participants. 
 
5.3.3.3 Work-module (Q - DASH) 
At baseline and three months’ post treatment both groups had the same scores for 
upper limb function. There was a more noticeable improvement in upper limb function 
in the intervention group compared to the control group one-week post treatment 
(table 4.8).  However, no statistical significance was found indicating that the null - 
hypothesis was accepted. 
 
The literature states that manually intensive occupations could have statistically 
significant impact on LET (Walker-Bone et al., 2012).   
 
 
5.3.3.4 Sport Characteristics 
There was no statistical significance found between the intervention group and 
control group for sport characteristics, the groups were evenly matched (table 4.2).  
 
In this clinical trial 62% of participants in the intervention group participated in sport, 
whereas 50% of the participants in the control group participated in sport.  Gym was 
the sport most of the participants participated in, with 15% of participants in the 
intervention group and 50% in the control group.  However, there were less 
participants participating in golf, tennis, squash and table tennis, with 15% of 
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participants in the intervention group and 10% in the control group participating in 
these sports (appendix 15). 
 
Literature however indicates that chronic lateral elbow tendinopathy has a substantial 
impact on athletes (Longo et al., 2012).  In a review by Abrams, Renstrom and 
Safran, (2012) on the epidemiology of musculoskeletal injury in the tennis player it 
was found that lateral elbow tendinopathy is one of the most common overuse 
injuries in tennis, particularly in the recreational tennis player, they reported that the 
overall prevalence of lateral elbow tendinopathy was between 35%-51% which is 
much higher than the 1.3% found in the general population.   
 
5.3.3.5 Sport-Module (Q-DASH) 
The intervention group had better function at baseline and three month’s post 
treatment.  Both groups had improvement in upper limb function during sport activity 
when comparing baseline to three months’ post treatment (table 4.9), however there 
was no statistical significant difference found between the intervention and control 
group.  The sport - module of the Q-DASH had a lower response rate as it was an 
optional module, and many participants of this study did not complete this optional 
module (refer to appendix 15 where 18 of the 41 participants did not complete the 
module).  This could possibly explain the aforementioned results. 
 
           5.4 CONCLUSION 
 
This study was thus unable to prove the efficacy of radial shockwave treatment with 
regards to pain, grip strength and upper limb function.  This finding is supported by 
















             
The limitations of the study, implications for future research as well as the clinical 
implications will be discussed briefly in this conclusive chapter. 
 
The intervention group presented similarly to the control group. The research 
hypothesis was thus rejected in this study stating that there will not be a significant 
improvement in upper limb function, grip strength and pain in patients with chronic 
lateral elbow tendinopathy treated with radial shockwave treatment, compared to 
patients receiving placebo treatment.  
 
There is insufficient evidence regarding the long-term effects of radial shockwave 
treatment.  Patient selection criteria (inclusion and exclusion criteria) have not been 
adequately defined.  Optimal treatment parameters (type of shockwave, application 
methods used, dosage-intensity, specifications of apparatus, focal energy, treatment 
frequency, localisation methods and combination of therapies) have not been 
established either.  
 
6.2 LIMITATIONS OF THE STUDY  
 
There are notable limitations to this study such as the small sample size.  Over a 
period of two years 41 participants with lateral elbow tendinopathy were recruited to 
participate in this clinical study.  The calculated sample size for this study was 70 but 
due to the difficulty and slow recruitment numbers over two years it was decided to 
halt recruitment after two years of data collection.  The small sample size could 
explain the lack of statistical significance.  
 
The “long term” follow-up period after the radial shockwave treatment could possibly 
have been extended from three to twelve months to determine the long-term effect of 
the intervention on LET.  This would thus make provision for the natural progression 
of the condition which could be more significant at twelve months, than at three 
months follow up.   
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Although this study was conducted based on the best practise guidelines found in the 
literature, optimal (patient-specific) treatment parameters were not established.  The 
causes and duration of LET also need to be considered as it could determine the 
treatment dosage and outcomes. 
 
 
6.3 IMPLICATIONS FOR FUTURE RESEARCH 
 
A consistent effective radial shockwave treatment protocol for chronic LET with 
clearly defined variables needs to be researched.  There are many variables affecting 
the protocol of shockwave treatment such as the type of intervention (type of 
shockwave and exact dosage), outcomes measures (validity and reliability), selection 
criteria for participants (inclusion and exclusion criteria), and the length of time for 
follow-up evaluation (long-term follow up could be extended to one year after the 
intervention).  Larger, well designed RCT’s need to be conducted in order to evaluate 
best treatment practises and protocols of radial shockwave treatment for patients 
with chronic lateral elbow tendinopathy. 
 
6.4 CLINICAL IMPLICATIONS 
 
Until clear treatment guidelines of radial shockwave therapy are established, the use 
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▪ INFORMATION DOCUMENT 
 
Shockwave therapy in the treatment of chronic tennis elbow 
 
Good day 
We, Sandra Crafford and colleagues, are doing research on chronic tennis elbow. Research 
is just the process that we use to find the answer to a question. In this study we want to find 
out if shockwave therapy will be effective in treating chronic tennis elbow.  It is an alternative 
treatment where the usual treatment (medication, physiotherapy and injections) has not 
been helpful, and to avoid surgery we offer this as an alternative conservative physiotherapy 
treatment. 
 
In this study there are two groups, one group receiving shockwave treatment and the other 
group receiving sham treatment.  Each patient will be evaluated by filling in questionnaires 
about the amount of pain when using the arm, and the functioning of the arm.  By palpating, 
(feeling on the painful area), testing the grip strength with a measuring instrument and then 
to rate the pain on a scale of 1-10.   Each patient will have three treatments once a week.  
An evaluation and treatment should take no longer than half an hour.  After the three 
treatments the patients will be followed up at one week and three months after the last 
treatment. All patients will receive an exercise programme to do at home. 
 
In this treatment shockwaves are passed through the skin to the affected area (elbow). The 
possible side - effects involved with this treatment could be local pain and discomfort, 
bruising and reddening of the skin as well as swelling of the treatment area; if any side - 
effects should occur they won’t last long. 
 
The benefits of participating in this study is that, it is an alternative treatment to the previous 
treatment received (physiotherapy, splints, medication including tablets and injections) which 
didn’t relieve the symptoms, and the treatment is free of charge if you should decide to 
participate in this study. 
 
You as the patient have already received abovementioned routine treatment and could wait 
and see if the symptoms improve or can consider surgery.  If you decide to take part in this 
study, you will not lose any benefits or be penalised in any way.  You may withdraw consent 
to this study at any time. Every effort will be made to keep personal information confidential, 
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absolute confidentiality cannot be guaranteed as, personal information may be disclosed if 
required by law. 
 
The research ethics committee and the medicines control council may inspect or copy the 
research records for quality control.  The results may be published and that may lead to 
individual or group identification. 
 
Contact details of researcher: Sandra Crafford – 082 787 5265 
For further information, or reporting of study -  related adverse effects. 
Contact details of REC administrator: Ms Anisa Keshav – (011) 717 1234 
REC chairman: Professor P Cleaton-Jones – (011) 717 1234 



















▪ CONSENT FORM 
 
 
I _________________________ hereby give written consent to participate in the study that 
Sandra Crafford is doing for her Master’s degree in Physiotherapy. 
 
 
I have read and understand the information document for the study of shockwave therapy in 
the treatment of chronic tennis elbow, and am aware of risks, benefits, alternative treatment 
and procedure of this study. 
 
 




I understand that it is within my rights to withdraw from this research, either verbally or in 
writing without any penalty or loss of benefits to which I am otherwise entitled. 
 
 
















▪ PERMISSION FROM OWNER OF CLINIC 
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▪ SAMPLE SIZE CALCULATION 
  
 
                                                                                                    Whitley and Ball (2002) 
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▪ DECLARATION OF HELSINKI 
 
652 Bulletin of the World Health Organization |August 2008, 86 (8) 
Special theme – Ethics and public health 
 
Declaration of Helsinki 
 
Recommendations guiding doctors in clinical research 




It is the mission of the doctor to safeguard the health of the people. His knowledge and 
conscience are dedicated to the fulfilment of this mission. 
 
The Declaration of Geneva of the World Medical Association binds the doctor with the words: 
“The health of my patient will be my first consideration” and the International Code of 
Medical Ethics declares that “Any act or advice which could weaken physical or mental 
resistance of a human being may be used only in his interest.” 
 
Because it is essential that the results of laboratory experiments be applied to human beings 
to further scientific knowledge and to help suffering humanity, The World Medical 
Association has prepared the following recommendations as a guide to each doctor in 
clinical research. It must be stressed that the standards as drafted are only a guide to 
physicians all over the world.  
 
Doctors are not relieved from criminal, civil and ethical responsibilities under the laws of their 
own countries. In the field of clinical research, a fundamental distinction must be recognized 
between clinical research in which the aim is essentially therapeutic for a patient, and the 
clinical research, the essential object of which is purely scientific and without therapeutic 
value to the person subjected to the research. 
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I. BASIC PRINCIPLES 
1. Clinical research must conform to the moral and scientific principles that justify 
medical research and should be based on laboratory and animal experiments or 
other scientifically established facts. 
 
2. Clinical research should be conducted only by scientifically qualified persons and 
under the supervision of a qualified medical man. 
 
3. Clinical research cannot legitimately be carried out unless the importance of the 
objective is in proportion to the inherent risk to the subject. 
 
4. Every clinical research project should be preceded by careful assessment of 
inherent risks in comparison to foreseeable benefits to the subject or to others.  
 
5. Special caution should be exercised by the doctor in performing clinical research 
in which the personality of the subject is liable to be altered by drugs or 
experimental procedure. 
 
II. CLINICAL RESEARCH COMBINED WITH PROFESSIONAL CARE 
1. In the treatment of the sick person, the doctor must be free to use a new 
therapeutic measure, if in his judgment it offers hope of saving life, re-
establishing health, or alleviating suffering. If at all possible, consistent with 
patient psychology, the doctor should obtain the patient’s freely given consent 
after the patient has been given a full explanation. In case of legal incapacity, 
consent should also be procured from the legal guardian; in case of physical 
incapacity the permission of the legal guardian replaces that of the patient. 
 
2. The doctor can combine clinical research with professional care, the objective 
being the acquisition of new medical knowledge, only to the extent that clinical 
research is justified by its therapeutic value for the patient. 
 
III. NON-THERAPEUTIC CLINICAL RESEARCH 
1. In the purely scientific application of clinical research carried out on a human 
being, it is the duty of the doctor to remain the protector of the life and health of 
that person on whom clinical research is being carried out. 
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2. The nature, the purpose and the risk of clinical research must be explained to the 
subject by the doctor. 
 
3a. Clinical research on a human being cannot be undertaken without his free 
consent after he has been informed; if he is legally incompetent, the consent of 
the legal guardian should be procured. 
 
3b. The subject of clinical research should be in such a mental, physical and legal 
state as to be able to exercise fully his power of choice. 
 
3c. Consent should, as a rule, be obtained in writing. However, the responsibility for 
clinical research always remains with the research worker; it never falls on the 
subject even after consent is obtained. 
 
4a. The investigator must respect the right of each individual to safeguard his 
personal integrity, especially if the subject is in a dependent relationship to the 
investigator. 
 
4b. At any time during the course of clinical research the subject or his guardian 
should be free to withdraw permission for research to be continued. 
 
The investigator or the investigating team should discontinue the research if in his or their 
judgement, it may, if continued, be harmful to the individual.  
 




APPENDIX 14  
▪ LIST OF OCCUPATIONS OF PARTICIPANTS 
 
1. Farmer  22. Admin work 
2. Piano teacher  23. Computer work 
3. Editor     24. Credit manager 
4. Machine setter   25. Housewife 
5. Hairdresser    26. Accountant 
6. Musician     27. Sound Engineer 
7. Sales Lady     28. Supervisor 
8. Table setter     29. Cricket coach 
9. Office clerk     30. Teacher 
10. Secretary  31. Admin work 
11. Consultant  32. Driver 
12. Housewife  33. Graphic design 
13. Marketing-Admin  34. Admin work 
14. IT-Specialist  35. Electrician    
15. Farmer/Businessmen  36. Nurse/Training 
16. CEO of company  37. General manager 
17. Computer work/Admin  38. Director of company 
18. Housewife  39. Handy man 
19. Project manager  40. Owner of company 
20. Customer relations/Admin  41. Works manager 
21. Supervisor work and maintenance    
 
Table:   Occupations of participants(frequencies) 
 
                                  Occupations of participants (Frequencies) 













▪ LIST OF PARTICIPANTS SPORT 
 
1. Enduro riding   22. - 
2. Musical instrument-Piano  23. - 
3. Gym/Guitar  24. - 
4. -  25. - 
5. -  26. - 
6. Guitar  27. - 
7. Bowls  28. Golf 
8. -  29. Cricket 
9. Cycling/Swimming  30. - 
10. Cake decorating  31. - 
11. Cricket  32. Gym 
12. -  33. Musical instrument-drums 
13. Cycling  34.  Gym 
14. Golf  35. Swimming   
15. Cycling/Cross Fit  36. - 
16. Gym  37. Gym 
17. Musical instrument-Piano  38. Golf/Tennis/Squash/Cycling   
18. Gym  39. - 
19. Squash/Gym  40. Squash/Tennis/Table tennis 
20. -  41. Cycling 
























4 (31%) 1 (10%) 
Gym 2 (15%) 5 (50%) 




2 (15%) 1 (10%) 
Cycling 4 (31%) 1 (10%) 
Enduro-riding 1 (8%) 0 (0%) 
Bowls 0 (0%) 1 (10%) 
Swimming 1 (8%) 1 (10%) 
Cake 
decorating 
0 (0%) 1 (10%) 
Crossfit 1 (8%) 0 (0%) 
Cricket 0 (0%) 1 (10%) 
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Dominant arm involved  
Work affects upper limb function  
Sport affects upper limb function  
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